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INTRODUCTION 
1. NORMAL IDSTOWGY OF THE LYMPH NODE 
In order to understand and interpret pathology of lymph nodes, a thorough understanding of 
normal lymph node histology is imperative. This is of importance whether dealing with 
malignant or benign conditions. 
Essentially, a lymph node can be divided into four zones in which different reaction patterns 
may take place. The type of antigenic stimulus and the stage of development of the 
corresponding immunological response will determine the particular predominance of one zone 
over another and the overall histological pattern. <3 ,4,3) 
The different zones are firstly, the follicle in which the germinal centre reaction takes place, 
which leads to the formation of precursors of antibody-forming cells and memory B-cells. 
Secondly, the medullary cords where the antibody-secreting (B) plasma cell reaction takes 
place. Thirdly, there is the paracortex where the specific cellular response takes place, 
generating antigen-specific T-cells and probably, memory T-cells. The sinuses are the fourth 
and last zone of a lymph node. Here macrophages clear the lymph through which antigens pass 
to the lymph nodes. Antigen processing by macrophages is also thought to take place here. <3 ,4,3) 
FOLLICLES 
The follicles are found in the cortex of the lymph node which lies in the outer portion of the 
node beneath the capsule. Two types of follicles exist. They are the primary follicle consisting 
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of aggregates of small dark-staining lymphoid cells, and the secondary follicle, formed after 
being antigenically stimulated and developing a so-called germinal centre and a surrounding 
mantle zone. 
The lymphoid cells of the primary follicle are small and round with slightly irregular nuclei and 
dark staining, condensed chromatin. They have scanty cytoplasm. Immunohistochemically, 
these are B-cells, reacting with monoclonal antibodies directed against B-cells. They are the 
same cells morphologically and immunohistochemically as the cells of the mantle zone of the 
secondary follicle. <3 ,4,8) 
In order for the germinal centre to function, ie for antigen-dependent amplification of a B-cell 
population, and subsequent generation of memory cells and precursors of the antibody-forming 
plasma cells, cooperation between the various cell · types within the germinal centre has to take 
place. The cells in the germinal centre are the follicular dendritic cell (FDC), lymphoid cells 
and tingible body macrophages. 
Although the precise function and derivation of the FDC is not known, they are thought to be 
part of the monocyte-phagocyte system, to trap antigen on their surface and to present it to 
B-cells. Morphologically, the FDC has a medium-sized to large nucleus, often elongated, and 
a very fine chromatin pattern and an inconspicuous nucleolus. The nucleus can on occasion be 
binucleated. The cytoplasm can only be visualised immunohistochemically where it shows 
many long, slender cytoplasmic protrusions. The FDC' s form a network with these protrusions 
which are linked via desmosomes. <3,4,8) 
The lymphoid cells of the germinal centre consist of a number of different cells showing 
varying morphological characteristics. Large noncleaved follicle centre cells (FCC) or 
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centroblasts are large, typically "blast" cells with large, vesicular nuclei and only a narrow rim 
of basophilic cytoplasm. One to three small but distinct nucleoli are present at the periphery of 
the nucleus. Mitoses are frequent and this cell is the proliferative cell of the germinal 
centre. <3,4,8> 
Cleaved FCCs or centrocytes are cells somewhat larger than lymphocytes with larger, more 
open nuclei and more cytoplasm. The nucleus varies in size with the size of the cell and is 
remarkable for its irregular contour, but it is the proportionate amount of cytoplasm that will 
determine whether the cell is a large or small centrocyte. 
Immunoblasts are large transformed lymphocytes, being formed upon exposure to an antigenic 
stimulus. They are therefore found in so-called "reactive" lymph nodes. They are of either B 
or T lymphocytic origin and, whether B or T display broadly the same characteristics. The 
nucleus is large and vesicular with a prominent central nucleolus. Cytoplasm is usually ample 
and basophilic in the more mature immunoblast and is less obvious at first. Those of the B 
phenotype start to resemble plasma cells as the cell matures. The cytoplasm of reactive 
immunoblasts stain with a more intense basophilia than their neoplastic counterparts. <8) 
Small noncleaved FCC or lymphoblasts are rare cells having a medium-sized nucleus and an 
inconspicuous nucleolus. They have scanty intensely basophilic cytoplasm. <4> 
Tingible body macrophages are large cells with medium-sized, inconspicuous nuclei. They are 
striking however, due to their abundant cytoplasm containing phagocytosed debris which 
imparts the so-called "starry-sky" pattern to the germinal centre. <4> 
Other cells that may be found within the germinal centre are occasional plasma cells and small 
lymphocytes with dark staining irregular nuclei. These are most likely T-lymphocytes. 
The cellular composition of the germinal centre depends on the phase of development following 
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an antigenic stimulus. The germinal centre usually develops 4 days following an antigenic 
challenge with centroblasts predominating. Macrophages then appear imparting the starry-sky 
pattern. This is followed by the appearance of centrocytes and larger numbers of FDCs, 
creating a polymorphic histological picture. <4) 
Zonation of the germinal centre then occurs. A dark zone containing centroblasts and a light 
zone consisting of centrocytes and FDCs, is formed. The light zone is found closest to the 
lymph node capsule and the dark zone directed toward the medullary region. cs) 
MEDULLARY CORDS: 
These occupy the central portion of the lymph node deep to the cortex and extends from cortex 
to hilum. These are the site of the plasma cell reaction where antibody is produced. 
The major cell in the medullary cords is the small lymphocyte. They have small nuclei and 
scant to moderate amounts of cytoplasm. Immunohistochemically, they are B cells, the 
medullary cords thus being a B-cell area. Occasional T-lymphocytes with less cytoplasm and 
more irregular nuclei are present. <4) 
The plasma cell has an eccentric nucleus with the typical spoke-wheel chromatin pattern. The 
cytoplasm is abundant and a clear hof is seen adjacent to the nucleus. PAS-positive globules, 
the so-called Russell body, maybe seen in the cytoplasm. <4) 
Immunoblasts having similar morphology to those found in the germinal centres can also be 
found. Macrophages are scarce but are seen. Mast cells, best visualised by the Giemsa or 
Toludine Blue stains, are also present. 
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PARACORTEX: 
This is the region just deep to the cortex and between the true cortex and medulla. This is the 
site of the specific cellular immune response where immuno-competent T-lymphocytes are 
generated. 
The major cell type is the small T-lymphocyte which has a small, irregular nucleus with dark, 
condensed chromatin and little cytoplasm. 
A highly distinctive structure is the epithelioid (or postcapillary or high-endothelial) venule. 
These vessels are lined by distinctive endothelial cells. In contrast to the flattened endothelial 
cells lining the usual blood vessel, these endothelial cells are plump and cuboidal with fairly 
large, round nuclei and small nucleoli. These cells have a high degree of metabolic activity 
and they play a crucial part in the recirculation, distribution and homing of lymphocytes. <4,8) 
The interdigitating cell (IDC) is the antigen presenting cell of the paracortex. It is a large cell 
with a large and bizarre nucleus having deep clefts and folds. The chromatin is delicate and 
nucleoli are inconspicuous. The cytoplasm is abundant, clear, and pale with ill-defined 
borders. <4,8> 
SINUSES: 
This compartment of the lymph node includes the subcapsular sinus and those sinuses which lie 
in the medulla between the medullary cords. 
The structures carrying lymph from the afferent to the efferent lymphatics are the sinuses. The 
afferent lymphatics drain into the subcapsular sinus. Sinuses then drain through the lymph 
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node toward the hilum. These are known as the medullary sinuses and are lined by 
macrophages. They are the first cells to come into contact with lymph-borne antigen and thus 
have an important phagocytic as well as antigen-presenting function. They are morphologically 
and immunohistochemically similar to macrophages found elsewhere in the lymph node. Small 
lymphocytes are also found in the sinuses. <4,8> 
2. HISTOPATHOWGY OF REACTIVE LYMPHOID HYPERPLASIA 
Histological examination remains the foundation of lymph node diagnosis. In order to perform 
an adequate lymph node examination, meticulous care must be given to surgical removal of the 
lymph node and its subsequent processing. Artifactual distortion of lymph nodes during 
removal and processing is often responsible for difficulties in diagnosis. <3,4,8•9> Cooperation 
between clinician and pathologist is essential. A representative node should be removed and 
the tissue submitted fresh with minimum delay between time of removal and processing in the 
pathology laboratory. The lymph node should be cut across the short axis so that complete 
cross sections are available for examination. Care should be taken not to squeeze the tissue, 
since undue pressure on the specimen may cause changes in the histology that might obscure 
the morphology. The delicate reticulin framework of lymph nodes is particularly susceptible to 
traumatic disruption. Maintenance of architectural features is essential in the histological 
interpretation of lymph nodes. Tissue for cytogenetics, electron microscopy and freezing 
should be taken and processed in the appropriate manner. At least one 1-2 mm section should 
be fixed in B5 fixative for 2 hours and then postfixed in a buffered formaldehyde solution for 
24 hours. This gives excellent morphology and enhances immunostaining of many antigens. 
One or more similar sections should be routinely fixed in a buffered formaldehyde solution. 
Routine staining of 3-4µ sections should include haematoxylin-eosin and a Giemsa. <3,4,8•9> 
Further special stains including immunohistochemistry, may be performed after initial 
histological examination. 
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Sophisticated techniques such as immunohistochemistry, electron microscopy, DNA analyses 
by flow cytometry and so on, must be interpreted in conjunction with histological assessment of 
well-fixed and processed tissue sections. 
An organised scheme of lymph node examination is necessary for diagnostic accuracy. <10> 
Dorfman and Warnke(3) have proposed a scheme for systematic lymph node examination which 
has been modified by Burke. <10> Within this scheme, the histological pattern based on changes 
in the cortex, paracortex or sinuses, is used to divide the lymph node into different reactive / 
architectural patterns which can be used to categorise specific disease entities. (J'able 1) 
Major criteria for distinguishing benign from malignant conditions are the degree of 
architectural effacement, the presence of cytological atypia, and whether the proliferation is 
polymorphous or monomorphous. <10•11> Difficulties in diagnosis are due to poor tissue 
preservation and fixation, coexistence of a reactive process with a malignant lymphoma, and 
exceptions to the usual morphological criteria. <10> 
Lymphomas are considered to be the malignant counterpart of normal immunological reactions 
to antigens in the lymphoid system, the lymphoma cells thus having similar morphologic, 
immunologic and functional characteristics when compared to normal cells. <4> This often makes 
distinction between benign and malignant processes very difficult. 
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TABLEl 
PREDOMINANT ARCIDTECTURAL PATTERNS OF REACTIVE LYMPHADENOPATHIES 
Follicular pattern 
Reactive follicular hyperplasia 
Nonspecific 
Florid 
Syphilis 
Rheumatoid arthritis 
Castleman' s disease 
Progressive transformation of the germinal centres 
Sinus pattern 
Sinus histiocytosis 
Sinus histiocytosis with massive lymphadenopathy 
Haemophagocytic syndromes 
Langerhans cell histiocytosis 
Whipple's disease 
lymphangiogram effect 
Vascular transformation of the sinuses 
Diffuse pattern . 
Viral lymphadenitis 
Infectious mononucleosis 
Herpes zoster 
Post vaccinial lymphadenitis 
Dilantin and other drug-induced hypersensitivities 
Angioimmunoblastic lymphadenopathy 
Atypical lymphoplasmacytic and immunoblastic proliferations 
Mixed interf ollicular and follicular pattern 
Dermatopathic lymphadenopathy 
Toxoplasmosis 
Necrotizing granulomatous inflammation 
Cat scratch disease 
Lymphogranuloma venereum 
Yersinia 
Histiocytic necrotizing lymphadenitis (Kikuchi's disease) 
Systemic lupus erythematosis 
Mucocutaneous lymph node syndrome (Kawasaki disease) 
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2(a) FOUICULAR (NODULAR) PATTERN 
All the processes listed under this heading may mimic the follicular lymphomas (FL). <3,4,lO) A 
thorough knowledge of the histological differences between benign, reactive follicles and the 
follicles of malignant lymphoma, is imperative. 
Reactive lymphoid follicles tend to vary in size and may assume bizarre dumb-bell shapes. 
Their margins are however, well defined and there is a surrounding mantle of small 
lymphocytes, the so-called mantle zone. There is a low number of follicles per surface area of 
the lymph node parenchyma and a predominant cortical location of the follicles. The follicles 
themselves are composed of an admixture of large and small lymphocytes, a high number of 
FDCs which form a well-developed and intact meshwork, and tingible body macrophages. 
Plasma cells are often seen and normal mitoses are frequent. In contradistinction, the 
histological features of follicular lymphoma include a uniform nodularity through the node with 
little variation in the size and shape of the follicles, and lack of definition with peripheral 
fading and occasional coalescence of the follicles. Tingible body macrophages are rare and 
mitoses are less frequent than in reactive follicles. (3) 
In one form of reactive follicular hyperplasia, namely, florid reactive follicular hyperplasia 
(FRFH), differentiation from follicular lymphoma can be particularly difficult. FRFH is 
defined as the presence of numerous follicles throughout the cortex and medulla of the lymph 
node. <12> In a study of 80 cases of FRFH by Nathwani et al, they found the most useful criteria 
for distinction from follicular lymphoma to be the type of follicular pattern, the number of 
follicles per unit area, the cytological features of the cells in the interf ollicular tissue, and the 
number of benign histiocytes within follicles. Features of follicular lymphoma were: follicles 
evenly distributed throughout the node with little intervening tissue, ie a back-to-back 
arrangement of the follicles; the follicles could be of varying size and shape, a feature thought 
to indicate benignity; 60 or more follicles per unit area (ie a low-power-field area of 
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16.466mm2); the presence in the interfollicular tissue of large numbers of follicle centre cells 
having cytological features similar to those of the cells within the follicles; and less than 100 
benign histiocytes within five follicles. The first two criteria were considered to be the most 
useful. Ct 2) 
Immunohistochemical detection of BCL-2 protein is of established value in distinguishing 
between follicular lymphomas and follicular hyperplasia, as the follicle centre cells of reactive 
germinal centres do not express BCL-2, in contrast to follicular lymphomas in which up to 90% 
of cases show expression of BCL-2 by follicle centre cells. (B) 
FIGURE 1 - Reactive lymph node hyperplasia with giant follicles 
FRFH should not be confused with the entity of reactive lymph node hyperplasia with giant 
follicles, (RHGF).°3) (see figure 1) This again represents an extreme variant of reactive 
follicular hyperplasia which may be difficult to differentiate from follicular lymphoma. 
Microscopically, the enlarged giant follicles involve the entire area of the lymph node section, 
frequently assuming a serpentine configuration resulting from coalescence of follicles. In a 
study of 22 cases by Osborne et al, 11 had been misdiagnosed as follicular lymphoma. No 
specific aetiological agent could be identified, certainly none usually associated with reactive 
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follicular hyperplasia. No recurrences occurred in a follow-up period ranging from 6 months 
to 15 years. <13) 
Malignant proliferations are not always monomorphous. Hodgkin's disease, particularly in the 
early stages when the infiltrate involves only small parts of the lymph node, and especially the 
interfollicular areas, is a case in point. <4, l 4) "Interfollicular Hodgkin's disease", first described 
by Doggett et al in 1983, is characterised by florid reactive hyperplasia, so much so as to 
overshadow the interfollicular involvement by Hodgkin's disease. This pattern may therefore 
be mistakenly diagnosed as one of the many causes of reactive follicular hyperplasia. <15) 
However, Fellbaum et al studied 25 cases in which the lymph nodes were suspicious for early 
interfollicular Hodgkin's disease. The diagnosis could not be established because of lack of the 
classic Reed-Sternberg cell. None of their cases progressed to Hodgkin's disease and they 
propose a lesion which appears to represent a distinct variant of lymphadenitis. <14) 
At least 75 % of patients suffering from rheumatoid arthritis (RA) will at some stage present 
with lymphadenopathy which may be localised, associated with an inflamed joint, or 
generalised. In these instances, it is not always possible to differentiate this lymphadenopathy 
" 
from malignant lymphoma, which is increased in incidence in these patients. For that reason, a 
lymph node biopsy may be performed. The histology has been described as showing florid 
reactive follicular hyperplasia throughout cortex and medulla and prominent plasmacytosis in 
the interfollicular region. Mitotic activity and tingible body macrophages are prominent 
features within the reactive follicles. Capillary endothelial hyperplasia in the interfollicular 
zones is a consistent finding as are polymorphs in both sinuses and paracortex. <16) In a study by 
Kondratowicz et al of 16 lymph nodes from patients with RA compared to 10 controls, reactive 
follicular hyperplasia was striking. They found however, that proliferative activity as assessed 
by the mitotic rate, and the presence of tingible body macrophages and centroblasts, was less 
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common when compared to controls. The plasmacytosis and capillary endothelial hyperplasia 
in the interfollicular region was confirmed. Polymorphs were prominent but not increased 
more than in controls.<17) 
Malignant disease may be considered in patients suffering from syphilis who present with 
generalised lymphadenopathy. The histological changes are predominantly those of follicular 
hyperplasia, sometimes of such a degree as to mimic FL. <4•18> Striking features are oedema of 
the capsule and extensive fibrosis of the capsule and pericapsular tissue. The capsule and the 
trabeculae may show infiltration by lymphocytes and plasma cells, which tend to aggregate 
around small blood vessels. (3 , l 8) Stansfeld finds the expansion of the T-zones the most 
conspicuous feature. Here, blood vessels are prominent and there is a mixed cellular infiltrate 
including large isolated immunoblasts imparting a "peppered" appearance to the lymph node, a 
feature seen in some viral diseases. Microscopic foci of necrosis may be present. a,22> 
Sarcoid-like granulomas have been described in regional lymph nodes from patients with luetic 
disease. <4> 
The disorder known as Castleman's disease (CD) was first described by Castleman et al in the 
1950's, and is an example of lymph node hyperplasia of the follicular type. It has been 
variously called angiofollicular (or giant) hyperplasia, lymph nodal hamartoma, follicular 
lymphoreticuloma, angiomatous lymphoid hamartoma amongst others. <8•19> Initially, two 
varieties were described and categorised. <8•19•20•21> These are localised CD of hyaline-vascular 
(HV) type and localised CD of the plasma cell (PC) type. A third variety known as 
"multicentric" or systemic CD (SCD) was later described. <8•19•22•23•24•25> 
CD, HV type (see figure 2) is the commonest comprising 90% of cases and presenting mostly 
between the ages of 30 and 40 and in either sex. It is most often an intrathoracic mass (75%), 
the anterior mediastinum being the commonest location, and does not have systemic 
manifestations. <8•19•20> Histologically a range of appearances may be seen depending on the 
I 
stage of the disease. The most characteristic feature is numerous, evenly distributed "follicles" 
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with abnormal germinal centres. <19> The boundaries of the follicle-like structures are well 
defined and they have whorled centres resembling Hassell' s bodies. (20) The follicles are of 
varying size, being medium to small although large follicles may be present. They are 
penetrated by numerous vessels with tall endothelial cells and hyalinised walls. <19•20> The 
follicle centres are composed mostly of pale, eosinophilic cells with few or no follicle centre 
cells (FCC). These eosinophilic cells often assume a concentric arrangement surrounded by 
layers of lymphocytes giving an "onion-skin" appearance. <3,19> The interfollicular areas have 
large numbers of vessels growing in anastomosing channels forming a network of blood 
vessels. In addition, small lymphoid cells are found in the interfollicular areas. <3,19•20> The 
diagnosis of CD, HV type should only be made when there is a combination of both abnormal 
germinal centres and hypervascular interfollicular tissue as the characteristic germinal centres 
may be seen in other conditions such as the lymphadenopathy in illV-infected .individuals and 
even in non-descript reactive nodes. <19> 
FIGURE 2 - Castleman's disease - Hyaline vascular type 
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CD, PC type is rare, constituting only 10% of cases of localised CD. <3,19•20•21) The age range is 
wide with a median age of 22 years. Sex incidence is equal. (20) Systemic manifestations such 
as fever, anaemia, and hypergammaglobulinaemia amongst others are frequent, being seen in as 
many as two-thirds of patients. <2°·21) The striking histological feature is that of numerous 
plasma cells in the interfollicular zones. These plasma cells form continuous sheets which 
encase the germinal centres and their mantle zones. <3,19•20•21) The plasma cells show mostly a 
mature morphology but some have larger nuclei or occasionally are multinucleated. (20) 
Interfollicular vascular proliferation is not a feature. <19) Reactive follicular hyperplasia is seen. 
Whilst some authors state no particular vascularization or hyalinization of follicles in the PC 
type<19\ others describe the presence of follicles typical of those seen in the HV variety. <3•20) 
These may represent "transitional" or "mixed" types which do not have the systemic 
manifestations described in the PC type. <19) 
The pathogenesis of CD, HV type is thought to be a chronic, reactive lymphoid hyperplasia of 
unknown aetiology but possibly infective although no organism has been implicated. <19) Current 
opinion is that the pathogenesis of CD, PC type is an inflammatory process, either due to 
chronic inflammation or antigenic stimulation, or due to an autoimmune process. <19) CD, PC 
type might be a proliferation of the autoantibody-producing CD5 + B-cell subset, sustained by 
local factors such as interleukin-6 which is produced by germinal centre cells. <5) It should be 
borne in mind, that interfollicular plasmacytosis is commonly seen in a wide variety of reactive 
lymph node conditions including RA and other autoimmune diseases, syphilis, and in nodes 
draining malignancies and skin diseases. <5,3,19,20) 
SCD or "multicentric" CD is the third variant of this reactive condition. It is a multisystem 
disorder having clinical as well as histological similarities to the PC type<8•19) but is a distinct 
clinicopathological entity within the atypical lymphoproliferative disorders. <5,3,22•24) Frizzera et 
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al have proposed strict diagnostic criteria requiring all 4 of the following to be met: 
a) the histologic features in the lymph node are those of CD, PC type. 
b) the clinical presentation is predominantly lymphadenopathic, with involvement of multiple 
and peripheral nodes. Deep lymph nodes such as abdominal and mesenteric are uninvolved 
at presentation. 
c) the involvement is multisystemic. The organs most commonly involved are the bone 
marrow, liver and kidney, and the central and peripheral nervous systems. Systemic 
symptoms are common. 
d) the histological and clinical changes can not be attributed to a known cause. This is 
because the changes are non-specific and may be found in a variety of other conditions 
such as autoimmune diseases, especially RA, HIV-related lymphadenopathy and lymph 
nodes involved in primary Kaposi's sarcoma. <5, 19,22,24> 
The disease runs a persistent or episodic course, and the mortality rate is high (50%). Some 
patients, especially in Japan, manifest with the so-called POEMS Syndrome, comprising a 
combination of polyneuropathy, osteosclerotic myeloma, endocrinopathy, serum monoclonal lg 
and skin changes. Variants of this syndrome exist, and may include the distinctive cutaneous 
lesion of glomeruloid haemangioma. <5> 
Immunohistochemical studies have shown the plasma cell proliferation in SCD to be 
polyclonal, but cases of monoclonal SCD have been described. cs,19> The pathogenesis is 
unknown and the association of SCD with other plasma cell disorders is speculative. <19> 
However, amongst the other atypical lymphoid hyperplasias in lymph nodes, the differential 
diagnosis of SCD should include lymphoplasmacytoid lymphoma and nodal plasmacytoma. <19> 
Progr~ive transformation of germinal centres (PTGC) is a form of reactive follicular 
hyperplasia whereby reactive follicles become further enlarged by a diffuse infiltrate of small 
lymphocytes and the border between the germinal centre and the lymphocytes of the mantle 
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zone become blurred. The normal histology of the germinal centre (centrocytes, centroblasts, 
dendritic reticulin cells, plasma cells, and tingible-body macrophages) is lost in this mass of 
lymphocytes. (26-29> The pathogenesis of PTGC is unknown and in itself is not neoplastic but a 
form of abnormal follicle development. Its importance lies in its frequent association with 
nodular L&H (lymphocytic and histiocytic) Hodgkin's disease (HD). PTGC can be found either 
before, after, or at the same time as nodular L&H HD, and is therefore an important indicator 
of possible lymphoma. (26-29> 
2(b) SINUS PATIERN 
A predominantly sinus pattern in a lymph node includes a number of conditions which have as 
their characteristic feature, a proliferation of histiocytes. They are sinus histiocytosis, sinus 
histiocytosis with massive lymphadenopathy (SHML), haemophagocytic syndromes, 
Langerhans cell histiocytosis (LCH), and Whipple's disease amongst ·others. The histiocytes in 
these conditions other than the LCH, have an antigen processing or phagocytic function. (30) 
Histiocytes of lymph nodes are not however, only found in the sinuses and comprise cells such 
as the FDC of the germinal centre and the IDC of the interfollicular areas.<1 1•30> These 
histiocytic cells have an antigen presenting or dendritic function. Proliferative lesions of these 
cells do not result in a sinus pattern of lymph node enlargement. 
Simple sinus histiocytosis is a common finding in lymph node examination and is usually 
without significance. In this pattern, the sinuses are distended with large numbers of 
histiocytes. They are uniform with an absence of atypia, and mitoses are rare. It is often seen 
in lymph nodes draining malignancies and the lymphocytes frequently contain pigment or 
1. ·ct (8) 1p1 . 
Whipple's disease 1s a multisystem disease usually involving the small bowel. Here, 
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collections of histiocytes are found in the lamina propria and submucosa of the bowel wall. 
These histiocytes contain abundant foamy cytoplasm which is in fact made up of bacterial 
debris and can be demonstrated with the use of special stains such as the PAS stain. These 
histiocytes are not however confined to the bowel wall but may be found in lymph node 
sinuses. <3> 
Lymph sinuses may become distended with clear globules of oil-contrast medium following 
lymphangiography. These globules may be seen spilling into the dense pulp of the lymph node 
as well. <3> 
Langerhans cell histiocytosis (LCH), formerly known as Histiocytosis X, is a multisystem 
disorder of childhood involving numerous organs such as bone, lung, skin, bone marrow, 
thymus, spleen, lung and liver amongst others. Localised, adult forms of the disease do also 
occur. It is thought to be a disorder of immune regulation rather than a fully developed 
neoplastic process and involves a proliferation of the Langerhans cell (LC). <3o,31> 
Lymph nodes are involved in 30% of cases and lymphadenopathy may be the first and only 
sign of LCH. Lymphadenopathy is seen in 2 situations: 
a) in association with neighbouring osseous disease, only nodes draining the lesion being 
involved and thus being a focal process, 
b) and lymph node involvement without bony disease. This involvement 1s also 
focal. (30,31) 
Histologically, the process is sinusoidal but may be so extensive as to lead to partial effacement 
of the lymph node architecture. Sheets of the characteristic LC, sometimes forming 
"granulomas", are seen in an inflammatory background consisting of eosinophils, neutrophils, 
and lymphocytes. Multinucleate giant cells, foam cells and siderophages may also be seen 
especially in patients with long-standing disease. Necrosis may be evident and can be extensive 
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on occasion. <3o,3 t> It has been well documented that malignant lymphoma may coexist with 
LCH. Most often it is HD but non-Hodgkin's lymphoma has also been described. It is thought 
that the LCH may be peculiar reaction to the lymphoma. <32> 
Conditions to be considered in the differential diagnosis are the exceedingly rare true histiocytic 
lymphoma, large cell immunoblastic lymphoma with sinusoidal involvement, metastatic 
tumours in which the malignant cells take on an epithelioid or histiocytic appearance (described 
most often in malignant fibrous histiocytoma), and monocytoid B cell proliferations. Here 
collections of a subpopulation of B cells are found within the sinuses. This occurs in a variety 
of reactive conditions such as toxoplasmosis and infectious mononucleosis. (30) 
In 1969, Rosai and Dorfman described 4 cases of a distinct clinicopathological entity which 
they called sinus histiocytosis with massive lymphadenopathy (SHML), which has since also 
been referred to as Rosai-Dorfman disease. <33> They foUowed up that report with an analysis of 
34 cases having the same clinical and pathological features. <34> Patients are usually young and 
present with painless cervical lymphadenopathy, fever, leucocytosis with neutrophilia, elevated 
sedimentation rate, and hypergammaglobulinaemia. The disease is not confined to lymph nodes 
and extranodal involvement in most organ systems is well described <34,35> Most often a 
precipitating event is not apparent but, not infrequently, the onset is preceded by a short 
non-specific illness. The aetiology is not known but infectious agents and immune 
derangements are postulated. <34,35> 
Macroscopically, the lymph nodes are enlarged and matted together, are firm in texture, and 
have yellow granular areas on cut section. The microscopic features are distinctive. There is 
marked capsular and pericapsular fibrosis, the fibrous tissue often infiltrated by lymphocytes 
and plasma cells. The lymph node sinuses are expanded by numerous distinctive histiocytes 
having round or oval, vesicular nuclei. Usually a single nucleolus is present but some cells 
have multiple nucleoli. Some nuclear atypia may be present but this is not a prominent feature. 
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Mitotic figures in the histiocytes are not often seen. A characteristic feature is the presence of 
well preserved lymphocytes and less often, red blood cells and neutrophils, within the 
cytoplasm of the histiocytes, a phenomenon referred to as lymphophagocytosis or 
emperipolesis. <33,34,35> Plasma cells are often seen in the distended sinuses. Occasionally, the 
histiocytic proliferation may result in effacement of the lymph node architecture. <35> 
Included in the differential diagnosis are metastatic melanoma, metastatic carcinoma, 
Hodgkin's disease, a variety of infectious diseases including leprosy and Histoplasma, and 
LCH<34,35> Simple sinus histiocytosis is the condition most commonly confused or most difficult 
to separate from SHML. In SHML, the histiocytes tend to have larger nuclei, nucleolar 
prominence, and obvious emperipolesis which is rare or absent in sinus histiocytosis. Most of 
the histiocytes in SHML will stain positively with S-100 immunohistochemical stain, while only 
a few will stain in simple sinus histiocytosis. C35> 
Another condition characterised by histiocytic infiltration in lymph node · sinuses, is the rare 
haemopbagocytic syndrome (HPS). Here, benign, normal-looking reactive histiocytes are 
seen containing platelets and red blood cells in their cytoplasm. The rest of the lymph node 
usually shows lymphocytic depletion. The diagnosis is more readily made on bone marrow 
aspiration. The pathogenesis is thought to be related to a response to a viral infection in a 
patient who is immunocompromised. However, cases have been reported in which the patient 
does not have an antecedent history of immunoderegulation. Here it is postulated that the HPS 
is as a result of excessive lymphokine production by normal or neoplastic T lymphocytes. (30) A 
case of HPS has been associated with the EBV in which the EBV genome was detected by the 
polymerase chain reaction in bone marrow and lymph node specimens. (36) 
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2(c) DIFFUSE PAITERNS 
This type of reaction pattern is probably the most difficult architectural disturbance in a lymph 
node to distinguish from malignant lymphoma. Common to most conditions falling into this 
category is the proliferation of reactive immunoblasts which are indistinguishable from 
malignant immunoblasts on morphological grounds alone. (3,8•10> 
In a study of of 20 cases of postvaccinial lympbadenitis by Hartsock, 9 were misdiagnosed as 
malignant lymphoma, 6 of the 9 being diagnosed as HD. (37) These cases presented following 
vaccination against smallpox, but may also be seen after vaccination against tetanus, typhoid, 
petussis, influenza, diphtheria, and the Salk vaccine against polio. Hartsock believes the 
hyperplasia to be due to a reaction to the vaccinia virus itself, to other antigenic components of 
the vaccine, and to an individual hypersensitivity to the vaccine. Four histological changes are 
typical but not exclusive to this group: 
a) hyperplasia of the lymph node which is usually diffuse but may be follicular, or a 
combination of both patterns 
b) an increased number of immunoblasts imparting a mottled appearance to the lymph 
node. 
c) sinusoidal and vascular changes. Prominent endothelial lined capillaries may be seen 
distributed throughout the stroma, a pattern sometimes seen in HD of the mixed 
cellularity type. 
d) a mixed cellular response comprising eosinophils, plasma cells and mast cells, again 
making the distinction from mixed cellularity HD very difficult. (3 ,8•37) 
The changes described above are not unique to postvaccinial lymphadenitis, but may be seen in 
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a variety of virally induced lymphadenopathies. <4'8'38> Amongst these are the herpes-virus 
group, viz cytomegalovirus (CMV), herpesviruses 1, 2, 3 and 6.<8> Measles virus, a 
paramyxovirus, causes lymphadenopathy during its prodromal stage. Occasionally a lymph 
node biopsy may be performed. The histological changes are those of follicular hyperplasia, 
the centre of some follicles containing the characteristic multinucleate, giant cell or 
Warthin-Finkeldy giant cell. This cell should not be confused with the syncitial lymphoid cell 
seen occasionally in malignant lymphoma, especially centroblastic-centrocytic lymphoma<8> 
A variety of drugs are known to cause reactive lymphoid hyperplasia. Best known amongst 
these are the hydantoin derivatives, but many others such as the penicillins, phenylbutazone, 
some antipyretics and antimalarials, have been implicated. The pathogenesis appears to be a 
hypersensitivity reaction of the serum-sickness type and presents with fever, urticaria! rashes, 
and often widespread lymphadenopathy. <8•38> 
Histologically, the lymph node shows diffuse proliferation of immunoblasts · predominantly 
located within the T-zones, sometimes sparing the follicles. <8•38> However, when the follicles 
are obliterated and the postcapillary venules are prominent, distinction from 
angioimmunoblastic lymphadenopathy may be very difficult. <8> On occasion, the blast cells may 
assume binucleate or multinucleate forms and contain prominent nucleoli, thus closely 
resembling the Reed-Sternberg cell of HD. This, particularly when combined with a mixed 
cellular infiltrate comprising eosinophils and plasma cells, may be very difficult to distinguish 
from HD. <8'38> The fact that a high proportion of patients on hydantoin derivatives develop HD, 
further adds to the diagnostic dilemma. <8•39> The histological picture is not unique to drug 
induced lymphadenopathy but may also be seen in viral lymphadenitis, particularly infectious 
mononucleosis (IMN). <8> 
The virus par excellence known to simulate and often confused with malignant lymphoma, is 
the Epstein-Barr-virus (EBV). <1•8•40•41 •42> EBV is ~ ubiquitous organism causing the clinical 
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disease called infectious mononucleosis (IMN) or glandular fever. Most individuals become 
infected in childhood or early adulthood and symptoms range from an asymptomatic infection 
to a severe debilitating, prolonged illness<43 ,44> Its role as a cofactor in the pathogenesis of 
nasopharyngeal and Burkitt's lymphoma is well established,<2'6'45> and it has been implicated in 
the pathogenesis of NHL in HIV-infected individuals. (T) One of the clinical manifestations of 
EBV infection is lymphadenopathy. As a result the patient may be subjected to a lymph node 
biopsy especially if the disease runs a prolonged and atypical course. The histological changes 
depend on the stage of the disease at the time of lymph node biopsy but are well 
described. <3,41 ,42•46> Initially, hyperplastic follicles with germinal centres are seen. Later, a 
diffuse proliferation of reactive immunoblasts, some with marked cytological atypia, are seen. 
The initial site of this immunoblastic transformation is in the paracortex, but active 
proliferation will result in filling of the lymph node pulp by these reactive immunoblasts with 
disappearance of the follicles and effacement of the normal lymph node architecture. 
Moderate trabecular, capsular and perinodal invasion by immunoblasts is seen. <3,41 •42•46> Foci of 
necrosis varying from minute to extensive may be seen in individual cases. <3,41 ,45> These 
changes can be confused with NHL especially newly described entities such as T-zone 
lymphoma, peripheral T-cell lymphoma and T-immunoblastic sarcoma, where paracortical 
involvement by immunoblasts with persistence of follicles is seen. <39> However, Stansfeld<8> and 
Childs et al<41> point out features against NHL: the solid clumps of immunoblasts are 
interspersed by a polymorphous population of lymphoid cells and are rarely in large 
uninterrupted sheets; the immunoblasts are not uniform as in NHL but display a varying degree 
of cytoplasmic basophilia; immunoblasts, as in other viral infections, may be seen in large 
numbers in the sinuses, a feature not seen in NHL; lastly, the underlying reticulin structure is 
maintained in IMN as opposed to NHL where destruction of the reticulin framework occurs. 
The atypical nature of some of the immunoblasts has already been described above. This atypia 
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may take the form of binucleate or multinucleate forms which closely resemble the 
Reed-Sternberg (RS) cell of HD. This was first recognised by Tindle et al in 1972 <46>, who 
referred to these cells as "RS-like", and has since been confirmed by numerous 
authors.<2,3,40,41 ,42,45> EBY-induced lymphoid hyperplasia has often been confused with 
HD<40,41 ,42> and what has further complicated matters is the detection of the EBV by in situ 
hybridisation techniques in the RS cells<2,47,43> and elevated EBV titres in patients suffering 
from HD. (2) Tindle et al are at pains to point out the lack of specificity of the~ cells in the 
absence of other histological features of HD. <46> 
Angioimmunoblastic lymphadenopatby (AILD) or immunoblastic lymphadenopathy is a 
distinct clinico-pathological entity first described by Lukes and Tindle in 1975. This disease 
entity superficially resembles HD and they became aware of this condition whilst studying the 
pathological manifestations of HD. <49> For this reason it was and still is incorrectly diagnosed as 
HD. Clinically, it is characterised by generalised lymphadenopathy, hepatosplenomegaly, 
fever, skin rash, and haemolytic anaemia amongst others. <3,49•50•51> Histologically, the 
characteristic features are a triad of diffuse effacement of the architecture with either absent or 
"burnt-out" germinal centres, a striking proliferation of arborizing blood vessels, and a 
hypocellular mixed cell infiltrate including plasma cells, immunoblasts, lymphocytes, 
eosinophils, and histiocytes. The overall cellularity is diminished often giving a 
lymphocyte-depleted appearance. Other variable features include thickening of the capsule, 
infiltration of the capsule, the density and composition of the cellular infiltrate, and the 
presence of PAS positive, amorphous material in the interstitium. <3,49,50,51> In some cases the 
immunoblasts can be atypical with binucleate and multinucleate forms being present, but no 
typical RS cells. <50> 
It soon became apparent that cases of AILD in which aggregates of immunoblasts and clear 
cells were present in significant numbers, were in fact cases of T-cell lymphoma. Some have 
developed during the course of AILD. <3> 
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The pathogenesis of AILD is unknown but, particularly in view of the clinical manifestations, it 
is thought to be due to a "hyperimmune" or autoimmune state with malfunction of both T- and 
B-cells. <49,50,52,53 ,54> A case of AILD has been described following an episode of EBV infection 
by Seigneurin et al<55>, and Weiss et al have detected EBV nucleic acid sequences by either PCR 
or ISH in 96% of 23 cases of AILD or AILD-like lymphoma. <51> Here, they thought the EBV 
was more likely to be as a result of the disease, AILD patients having profound immunological 
derangements, rather than a cause. 
2(d) MIXED PATTERNS 
Considerable overlap in architectural appearance exists between the diffuse and mixed patterns, 
making the distinction between the two often quite arbitrary. Disease entities falling into the 
mixed reaction pattern may, on occasion be more diffuse on histological examination, and vice 
versa, depending on the stage of the disease .process. Again, a feature common to this group is 
a proliferation of reactive immunoblastic cells. <10> 
Toxoplasmic lympbadenitis is a case in point (see figure 3), being classed as a mixed reactive 
pattern by some authors(l0>, and diffuse by others <3>. Toxoplasma is not an uncommon cause of 
lymphadenopathy and may on occasion be biopsied for diagnostic purposes. The histological 
features are follicular hyperplasia, epithelioid cell clusters, and the so-called "immature sinus 
histiocytosis" or monocytoid B-cell hyperplasia. <8•56•57) The follicles are large and irregular with 
ill-defined germinal centres, a feature somewhat unusual in reactive lymphoid hyperplasias and 
due, in part to the presence of reactive immunoblasts which are seen within and at the borders 
of the germinal centres. Numerous mitoses are present within the germinal centres and tingible 
body macrophages are conspicuous. A striking and distinctive feature is the presence of 
clusters of epithelioid histiocytes which are seen throughout the pulp of the node often invading 
the follicles, one of the reasons for the blurring of the margins of the follicles. They resemble 
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the epithelioid histiocytes of tuberculosis but caseation is absent. <56'57) Monocytoid B-cell 
hyperplasia is not restricted to toxoplasmic lymphadenitis, but is in a variety of another reactive 
conditions found. Peripheral and central sinuses become expanded by medium-sized 
monocytoid cells which are, in fact a specific subpopulation of B cell. <3,57) A marked increase 
in plasma cells is seen in medullary cords and around blood vessels but also throughout the 
whole lymph node pulp. <56 '57) Confusion with malignant lymphomatous conditions may arise 
from the architectural disorganisation of the lymph node, the active proliferation of 
immunoblasts simulating a neoplastic infiltration, and the prominent histiocytic clusters which 
may resemble those sometimes found in association with HD. <56> Features in favour of a benign 
reactive process are the incomplete architectural disturbance, the presence of normal mitoses, 
the absence of typical RS cells, and the cellular infiltrate which is inflammatory in nature as 
well as the characteristic morphology and perifollicular / sinusoidal distribution of monocytoid 
B cells. This may need to be distinguished from monocytoid B cell lymphoma.<56> 
FIGURE 3 - Toxoplasmic lymphadenitis - showing monocytoid B-cells 
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FIGURE 4 - Toxoplasmi_c lymphadenitis - showing an epithelioid granuloma not typically abutting into a germinal centre as is characteristic 
of toxoplasmic lymphadenitis 
Dennatopathic lymphadenitis (DL) may result in clinically palpable lymph nodes which may 
on occasion be biopsied. DL occurs in patients with chronic dermatoses and has a well 
recognised histological picture. Most characteristic is expansion of the paracortical areas by 
histiocytes containing melanin, some containing lipids and some, haemosiderin. C58> These 
histiocytes have been identified immunohistochemically and ultrastructurally as IDC. A 
variable number of histiocytes having the features of Langerhan' s cells (LC) have also been 
identified, although these are in the minority. Some authors have, however, found significant 
numbers of LC in DL and suggest that these may be the dominant cell type of this condition. C59> 
DL is a benign condition, but its importance lies in its association with mycosis fungoides 
(MF), where the histological features of DL are seen with those of the malignant infiltrate. 
Often the DL obscures the identification of the malignant cells, giving the false impression of a 
more favourable prognosis. c58> 
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Cat-scratch disease (CSD) (see figure 5) is a bacterial ~fection of lymph nodes resulting in 
lymphadenopathy. Histologically, there is follicular hyperplasia and focal, acute microabscess 
formation characterised by central necrosis with neutrophilic leucocytes and surrounding layers 
of palisaded histiocytes. (3 ,60•61 '62> The necrotic areas are typically geographicai in shape, a 
feature particularly suggestive of CSDC61> but when they assume a stellate appearance, and if 
the biopsy has come from · the groii:i, the distinction from lymphogranuloma venereum (LGV) 
may be very difficult. (3) The aetiological agent has proven to be elu&ive, but a highly 
pleomorphic, gr~m-negative bacterium has been cultured from excised lymph nodes of patients 
with CSD. c62'63> Two organisms have been implicated, Afipia felis and Rochalimaea henselae, 
the latter also being implicated as the aetiological agent in bacillary angiomatosis. c62> The 
organism may on occasion be identified by use of the Dieterle's stain, which gives a positive 
result in 40% of cases, or the Warthin-Starry technique. c61 •62> 
FIGURES - Stellate necrosis of lymph node - Catscratch disease or LGV 
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Kikucbi's necrotizing lympbadenitis (see figure 6) is a clinicopathological entity initially 
described in Japan, but now well recognised in many other parts of the world. <64'65> Clinically, 
it typically affects young females who present with painful cervical lymphadenopathy. The 
histological picture is well described and is characterised by a patchy necrotizing process 
located mainly (but not exclusively) in the paracortical areas of the lymph node. The degree of 
necrosis varies from case to case, being focal in some to extensive in others. Nuclear debris is 
seen scattered throughout these areas of necrosis, as are a variable number of lymphocytes, 
immunoblasts, macrophages, and so-called plasmacytoid T-cells which are in fact monocytes. 
The macrophages actively phagocytose the nuclear debris and are often described as being 
atypical. Immunoblasts are also evident in the lymphoid tissue surrounding the areas of 
necrosis, as are foamy macrophages, giving a characteristic "mottled" appearance to the lymph 
node. A consistent and important histological finding is the absence of granulocytes · and the 
paucity, but not necessarily absence, of plasma cells. In most cases the capsule is intact and in 
some, a polymorphous infiltrate is seen in perinodal adipose tissue. <64•65 •66•67•68> 
Immunohistochemical studies have shown . that within the lesion, lymphoid cells represent 
20-40% of the examined cellular population and consist of peripheral T-lymphocytes, 
predominantly of the cytotoxic/suppressor phenotype. In double stained preparation·s, as many 
as 40% of these T-lymphocytes display markers of activation, expressing the 
proliferation-associated antigen, Ki-67.<67) The plasmacytoid "T cells" (monocytes) and 
macrophages are always negative for this antigen. <67) An attractive postulate as to the 
pathogenesis of Kikuchi' s disease is activation of monocytes by an as yet unidentified 
aetiological agent, resulting in the formation of plasmacytoid monocytes which could secrete 
lymphokines without granulocytic effect, and then perish by pyknosis. Macrophages would be 
attracted to these necrotic areas where they would phagocytose and digest degenerated cells and 
any possible aetiological agent. <67) · 
The aetiological agent for Kikuchi' s disease has never been established. Two cases having 
rapidly rising titres for the haemagglutination (HA) antigen for toxoplasmosis have been 
described.<69> Three cases of Kikuchi's disease described by Feller et al had proven infection 
with Yersinia enterocolitica of serogroup 9 or 3. (70) Many of the morphological features of 
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systemic lupus erythematosus (SLE) may be indistinguishable from Kikuchi' s disease, and the 
possibility of. Kikuchi's disease being a "forme fruste" of SLE has been strongly 
entertained. <66'68) Both diseases occur in young females and are often very difficult to separate 
on histological grounds. Features in favour of SLE over Kikuchi' s disease are the presence of 
some granulocytes, evidence of a vasculitis with onion skin formation in . the thickened vessel 
walls, and fibrinoid necrosis within residual follicles. Very rarely, haematoxyphil bodies may 
be found aggregated toward the edges of the necrotizing areas and in the sinuses. <68) Necrosis in 
SLE tends to be more widespread and the nuclear material may aggregate focally, leaving 
extensive areas of acellular necrosis. <66) 
FIGURE 6 - Kikuchi 's lymphadenitis 
Most importantly, the distinction from malignant lymphoma must be made. Kikuchi's disease 
has often been misdiagosed as either a high grade NHL or as HD on the basis of diffuse sheets 
of plasmacytoid monocytes. In Dorfman's and Berry's study of 108 cases, 40% were 
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diagnosed as large cell lymphoma or HD. <66) In a study of 25 cases by Turner et al, 10 ( 40 % ) 
were initially misinterpreted again as either large cell lymphoma or HD. <65) Karyorrhexis is 
likely to occur in high grade lymphoma and necrosis is not infrequently found in lymph nodes 
of patients with nodular sclerosing HD. Here, RS cells or variants thereof should be looked for 
around the necrotic foci. The necrosis can be of the coagulative or fibrinoid type. <66) 
Other entities which may mimic Kikuchi' s disease and which must be considered in the 
differential diagnosis, are cat scratch disease, IMN, the acquired immune deficiency syndrome, 
lymph node infarction, and Kawasaki's disease. <66) 
The spectrum of AIDS-related lympbadenopatbies ranges from benign lymphadenopathy to 
malignant lymphoma and reflects the immunological disturbances induced by the human 
immunodeficiency virus (HIV). Central to the pathogenesis is the tropism of the virus for the 
helper T-cell resulting in their destruction and the . subsequent unchecked stimulation and 
proliferation of B cells. (7l,72) Generalised lymphadenopathy is a common mode of presentation 
in HIV-infected individuals. Biopsies are usually performed to rule out malignancy or specific 
treatable infections which may be present as part of the disease process. (7l) Histological changes 
reflect the dynamic evolution of the disease. The most commonly observed pattern is that of 
florid follicular hyperplasia (FFH) or explosive follicular hyperplasia (EFH), the follicles 
having a geographical appearance and lacking · mantle zones, the so-called "naked 
follicles". (7l,73) Disruption of the follicle (follicle lysis) by small dark lymphocytes and 
haemorrhage can be seen in some follicles. (see figure 1f3) With progression of the disease, a 
phase of follicular involution (FI) occurs. Here follicles are small, hypocellular, and frequently 
hyalinized, with hypercellular paracortical areas and prominent interfollicular vessels. A mixed 
phase showing a combination of both FFH and FI can be found prior to the phase of FI. <73) 
With time, lymphoid depletion develops with absence of primary or secondary follicles. 
Residual germinal centres may be evident and are known as "regressively transformed" or" 
burnt-out" germinal centres. They are characterised by concentric layers of dendritic cells with 
foci of haemorrhage and a few lymphocytes. An increase in eosinophilic material in the lymph 
node pulp may also be seen and 1s . thought to represent necrotic cellular 
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debris. (7I,73) An histological feature often seen in association with the exuberant follicular 
hyperplasia, is proliferation of monocytoid B-cell lymphocytes (MBL) within the parafollicular 
sinuses. <72,74) In a study by Sohn et al of 22 lymph node biopsies in patients with AIDS-related 
lymphadenopathy, 17 showed MBL in association with florid reactive follicular hyperplasia. 
MBL was not seen in any of the cases showing involuted follicles or lymphocyte depletion. <74> 
Butler and Osborne maintain that the finding of florid reactive follicular hyperplasia together 
with MBL in parafollicular sinuses in 2 or more noncontiguous, noninguinal sites, warrants 
serological investigation for the detection of HIV. <72) MBL are not unique to AIDS-related 
lymphadenopathy, but may be seen in other conditions such as toxoplasma lymphadenitis. 
FIGURE 7 - AIDS - related lymphadenopathy - Follicle lysis 
Of specific concern in AIDS-related lymphadenopathy is the detection of malignancy in these 
lymph nodes. Most important amongst these are NHL and HD. In a review by Knowles et al 
of 105 patients with lymphoid neoplasia associated with AIDS, 89 had NHL, 13 HD, and 3, 
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chronic lymphocytic leukemia. C15> This again reflects the immune dysregulation allowing clonal 
expansion of a neoplastic population of B lymphocytes. The majority of NHL's in AIDS 
patients are high grade immunoblastic lymphomas of B phenotype, and undifferentiated or 
Burkitt-like lymphomas, exhibiting similar chromosomal translocations such as t(8: 14) and 
t(S:22), and c-myc oncogene activation, as seen in NHL's in non-AIDS patients. There are 
certain differences in the clinical behaviour, however. Extranodal lymphoma with advanced 
stage disease especially in the central nervous system, is common in AIDS-related NHL and 
HD. (71) Other lymphoma types such as the low grade and small-cleaved follicular centre cell 
lymphomas are encountered in HIV positive individuals, but less frequently. This poses 
diagnostic problems especially when they evolve in a background of abnormal lymphoid 
proliferation. (7l) 
Kaposi's sarcoma frequently presents as a lymphadenopathic disease and evolves in a situation 
of immunosuppression such as AIDS. Histologically there is a proliferation of disordered 
spindle cells containing slits filled with red blood cells. <8> Involvement may be more subtle with 
involvement of the subcapsular area leading to obliteration of the subcapsular sinus. (7l) 
Associations with the hyaline vascular form of Castleman's disease are well known. <8•11> 
Vascular transformation of the sinuses, a condition thought to arise on the basis of efferent 
lymphatic obstruction, should be considered in the differential diagnosis of Kaposi's sarcoma. <8> 
Kawasaki disease (KD) is an acute, exanthematous disease of childhood in which 
manifestations include acute nonsuppurative cervical lymphadenitis. Lymph node biopsy 
reveals characteristic features of multiple foci of necrosis and fibrin thrombi within the 
microvasculature. The necrotic foci are suggestive of microinfarction consequent to the 
intravascular thrombosis. Necrosis of lymph nodes is caused by a wide spectrum of disease 
processes such as tuberculosis, cat scratch disease, metastatic carcinoma, and lymphoma, both 
NHL and HD. These may be distinguished by careful cytological examination, KD causing a 
mixed lymphoid and immunoblastic response and RS-like cells never having been reported. (76) 
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3. THE ROLE OF EPSTEIN-BARR VIRUS IN LYMPHOPROLIFERA TIVE DISORDERS 
The Epstein-Barr virus (EBV) is a large 172 kilobase, double stranded DNA virus belonging to 
the herpesvirus family. <77,73> The herpesviruses have as a group the capacity to establish 
latency, ie the herpesvirus genomes remain in the resting state in a host cell. Reactivation gives 
rise to a temporary, mostly asymptomatic, viral shedding. (77) 
Primary herpesvirus infections occur most frequently in childhood and seldom cause severe 
symptoms. In industrialised nations EBV infection is often delayed to adolescence causing 
infectious mononucleosis (IMN). Burkitt's lymphoma (B~) and anaplastic nasopharyngeal 
carcinoma (NPC) are two EBV associated cancers. <1•2•77•73,79> More recently, EBV has been 
implicated in the aetiology of post-transplant lymphoproliferative disorders, Hodgkin's disease, 
brain lymphomas, oral hairy leucoplakia, and T-cell lymphomas.<1•78•80•31> However there have 
been few studies ·of EBV in reactive and atypical reactive lymphadenopathy. 
The usual route of infection with EBV is via salivary secretions, and the primary target cell is 
believed to be stratified squamous cells of the oropharynx where a largely lytic infection 
results, with production and release of new infectious particles. Secondary infection of 
trafficking B-lymphocytes by these progeny viruses results in the establishment of latent 
infection in the lymphoid compartment, which is the main site of virus persistence. <1•77•78•82> 
EBV gains entry into B-lymphocytes via the complement receptor CR2 (also known as CD21), 
which is expressed on human B-lymphocytes. o,77,32> · 
The exact mode of entry into the squamous cell has been unclear. Recently, evidence for 
antibody-assisted entry of EBV into certain epithelial cells has been provided. <32> Patients with 
NPC express antibodies of the IgA class to EBY-associated antigens in their serum. People in 
endemic areas who develop these antibodies have a 39-fold increased risk of developing this 
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epithelial tumour. Patients developing oral hairy leukoplakia, another EBV-associated epithelial 
disease seen in immunocompromised individuals, also express IgA antibodies to 
EBV-associated antigens. Most people who are infected with EBV mount a vigorous humoral 
response to viral antigens but do not express IgA antibodies to them in their serum. Some 
polarised epithelial cells, including some NPC display receptors for polymeric IgA (pigA). 
Polymeric IgA can bind this receptor, enter the cell, be modified to incorporate a remnant of 
the receptor, and be released from the opposite · face of the cell. It has been shown in cell 
culture that binding of EBV by specific anti-EBV pigA molecules mediates the entry of EBV 
into an established human epithelial cell that expresses the receptor for IgA. In this way, EBV 
is able to enter into an epithelial cell. <82> It has also been found that the infected cells express 
viral genes characteristic of the lytic phase of the viral life cycle. <82> 
In B-lymphocytes, EBV generally establishes latent infection, where once infected, B-cells 
carry the viral genome in their nuclei. The viral genome of non-replicating EBV exists in 
closed circles called episomes. <1•11•18•82> EBV infected B-cells either become small, resting cells 
or they are growth transformed into large, more mature lymphoblastic cell lines. (l ,77) In EBV 
infected B-cells, at least nine EBV associated proteins have been identified. · Six of these are the 
EBV nuclear antigens, EBNA 1-6. All infected B-cells probably express EBNAl and in the 
small resting B-cells, it is the only EBNA expressed. (77) 
EBNA 1 has two important functions essential to maintain the expression of EBV in the 
immortalized cells in its episomal form . It is required to mediate replication of the 
extrachromosomal viral plasmids present in the proliferating cells, and to activate at least one 
enhancer that affects a promoter that can yield several of the transcripts present in these 
cells. <79,83> 
EBNA 2 has been shown experimentally to initiate and induce transformation and to be 
involved in immortalisation by EBV. <77,79> This includes the up regulation of B-cell growth 
factor production and corresponding receptor expression. <83•84> 
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. · on~~ The functions of EBNA 3-6 are largely unknown. ' ' ' 
Another gene product, the latent membrane protein (LMP), is also thought to be involved in 
transformation and immortalisation. (17,79> It is encoded for by the BNLF-1 gene of EBV and 
acts as an oncogene in two established cell lines. (19) This oncogenic potential is of particular 
relevance given the strong implication of EBV in tumorigenesis. <33> Three leukocyte cell 
adhesion molecules, LFA-1, LFA-3, and ICAM-1, are increased in lymphoblastoid cells 
transfected by a vector expressing LMP and are thought to be effectors of lymphocyte 
growth. <35> The structure of LMP is also striking in that it resembles the protein encoded by the 
viral oncogene, the mas oncogene. It also bears a resemblance to the Na, Ca, and K ion 
channels, with six membrane scanning segments, and may thus be an ion channel. a9> 
Four monoclonal IgG1 antibodies, designated CS. l, CS.2, CS.3 and CS.4, have been 
synthesised, which when pooled together, recognise at least 3 different epitopes on the LMP 
molecule. <33> 
In addition, two non-polyadylated non-coding small RNA's referred to as Epstein Barr encoded 
RNA's (EBER-1 and EBER-2), are also present. These are expressed in high copy number in 
latently infected cells and are by far the most abundant transcripts (107 copies per cell) These 
small RNA's are 166 and 172 nucleotides respectively, and are located in the nucleus where 
they are bound to cellular La (lupus antigen) protein and EBER associated protein (EAP). <2•78•86) 
The secondary structure is stable and has recently been determined. Sites of interaction between 
EBER and La antigen have also been identified. <36> The exact function of the EBER' s is not 
known but they are potentially important in B-cell transformation. <36> 
Three different states of latency have been described characterised by distinctive patterns of 
restricted antigen expression. Latency I is characterised by expression of EBNA 1 and EBERs 1 
and 2 only, the pattern seen in Burkitt's lymphoma. Latency II has been identified in vitro and 
is transcriptionally distinct, being characterised by expression of EBERs 1 and 2, LMP, and 
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EBNA 1 in the absence of other EBNAs. Latency III, exemplified by latently infected 
lymphoblastoid cell lines, expresses EBNAs 1 to 6, LMP, and EBERs 1 and 2. <36> 
EBER's 1 and 2, and LMP can be identified by in situ hybridisation and immunohistochemistry 
respectively, and thus be used to identify cells latently infected by EBV in routinely processed 
paraffin sections, including archival material. These techniques have been used to identify 
EBV in cpnditions such as HD, NHL, nasopharyngeal carcinoma, and the atypical 
lymphoproliferations amongst others. <2,7,73,3o,37-9t> 
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4. IN SITU HYBRIDIZATION (ISH) 
4(a) BACKGROUND 
ISH is a technique relying on the reannealing of complementary sequences of nucleic acids. 
The nucleic acids remain in their cellular environment and this permits or enables for the 
, 
precise localisation and identification of individual cells containing a specific nucleic acid 
sequence. This is accomplished without altering the morphological information inherent in 
histological analysis and as such, offers a unique advantage over other molecular techniques 
such as Southern blots, Northern blots, dot blots, and the polymerase chain reaction 
(PCR). <92-95> The sensitivity of ISH is greater than any other of these molecular techniques, 
except for PCR. <95> The signal from homogenised tissue that is part of solution biochemistry is 
eliminated and the signal is localised in tissue that is histologically complex. <93> 
Immunohistochemical detection of a protein may provide similar information to detection of 
mRNA by ISH. However, the time and site of protein localisation may differ from than the 
time or site of transcription of its mRNA. A cell may contain a message for a protein (mRNA), 
but the protein may not be detectable immunohistochemically. Here ISH offers an advantage 
over immunohistochemistry in investigation of cell function . <93> 
The technique of ISH was first described in 1969 by _John et al in the UK and by Gall et al in 
the USA. <96•97) Early applications included the demonstration of ribosomal RNA (rRNA), 
messenger RNA (mRNA), and viral DNA. With time, refinements in the technology provided 
more rapid protocols and the production of labels with high specific activities and improved 
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probe purity. <94) 
ISH for mRNA allows identification of individual cells expressing specific genes as opposed to 
cells merely carrying a gene. <93) 
The basic principal of ISH involves the development of a labelled nucleic acid sequence 
(labelled probe), unmasking of target sequence by proteolytic enzyme digestion, hybridisation 
of the labelled probe through complementary base pairing to the immobilised target sequence, 
and detection of the hybrid by visualisation of the label. <94,93). 
1. ~ 
A C 
2. 
FIGURE 8 - The principles ofin situ hybridisation: l)labelled nucleic acid sequence; 2)hybridization through complementary base pairing; 
3)hybrid detected by visualization of label(94) 
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4(b) PROBE PREPARATION 
The production of pure, concentrated and standardised probes has been achieved through the 
emergence of DNA recombinant technology. Double stranded DNA (dsDNA) is ligated into the 
genome of a vector and large quantities of the introduced nucleic acid sequence are produced 
by amplification of this "hybrid". 
Labels (reporter molecules) must be incorporated into, or attached to, nucleic acid so that their 
annealing with target nucleic acid sequences can be visualised. This is most often achieved by 
enzyme incorporation of nucleotide analogues. <94,9s> 
Nucleotide analogues may be of 2 types; radioactive ie radioisotopes, or non-radioactive eg 
biotin-[d]UTP or Digoxigenin. Non-radioactive labelling offers a safety advantage, and probes 
labelled with biotin-[ d]UTP and other non-radioactive labels are stable for many months when 
stored at -200 C. In addition, they offer excellent resolution of target sequences. Their main 
limitation is that they lack the sensitivity of radio-labelled probes. This can be compensated for 
to some degree by the use of higher probe concentrations and multi-step detection systems. <94> 
An important feature of labelled probes is their overall sequence length. The smaller the probe 
the easier the penetration but, as they only hybridise a small portion of the target sequence, 
they lack sensitivity. This is the case of oligonucleotides which are small and can thus penetrate 
easily but lack sensitivity. <94> 
4(c) SAMPLE PREPARATION 
As DNA and RNA nucleases are present on the epidermis, gloves should be worn when 
handling samples, reagents and equipment. Autoclaving does not destroy RNase residing on 
glasswear. Glasswear therefore has to be treated with hydrogen peroxide, and solutions with 
diethyl pyrocarbonate prior to demonstrating RNA or using RNA-labelled probes. <94> 
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Sections tend to detach themselves from glass slides during hybridisation, and various 
techniques are required to ensure section adhesion eg APES-coated slides. C94,93> 
Most ISH techniques work in formalin-fixed, paraffin-embedded tissue, eliminating 
morphological artifacts present in frozen material. Delay in fixation of tissues results in 
denaturation of nucleic acids and loss of sensitivity. Some delay can, however be tolerated. 
Demonstration of total mRNA is unaffected by a one hour delay between excision and fixation 
in formal-saline prior to paraffin embedding. C94> Weiss and Chen found detection of mRNA to 
be most consistent and most intense with tissue fixed in formol-saline and Bouin' s solution, 
followed by B5 fixative, with OmniFix and ethanol fixatives yielding unsatisfactory results. C99> 
Single-stranded RNA is more labile than ds-DNA, but both do degrade over time. As long as 
the degraded mRNA fragments are of sufficient size (25 to 50 bases), and are trapped in the 
tissue, a specific signal will still be obtained. In a Northern blot technique, however, only a 
degraded smear may be seen in the same tissue. Once the tissue is properly fixed, the nucleic 
acids are stable essentially forever offering a unique opportunity for retrospective analysis in 
archival material. This also eliminates much of the risk associated with working with fresh 
clinical specimens. C93> 
Proteolytic enzyme digestion may be required to expose target nucleic acid sequences, 
depending on the type, time and conditions of fixation. Proteolytic enzyme digestion may also 
enhance the hybridisation signal, especially following on paraffin wax embedding. Proteinase 
K, pepsin and pronase have been used successfully as unmasking enzymes. The coupling of 
proteolytic enzyme treatment with other reagents such as hydrochloric acid and standard saline 
citrate, digitonin and TritonX-100 to aid t~e unmasking of target sequences, has been used in 
some protocols. C94•98> TritonX-100 is a detergent solution used to extract lipid membrane 
components. C98> 
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4(d) HYBRIDIZATION 
For hybridization to occur, probe and target sequences must be single stranded. When 
demonstrating DNA sequences, separation of the complementary strands prior to hybridisation 
is essential. This can be achieved by the extremes of alkaline pH or heat. This unfortunately 
may lead to loss of morphology and compromise sample preservation. <94,93> 
At a molecular level, hybridisation involves an initial nuclear reaction between a few bases, 
followed by hydrogen bonding of the remaining sequences. The control of temperature and 
monovalent cation concentration during hybridisation is important as variations in either will 
influence the specificity (stringency) of annealing. Following hybridisation, stingency washes 
are performed to remove unbound or loosely-hybridised probe, together with other constituents 
of the hybridisation solution. <94,93> 
4(e) DETECTION 
For the detection of radioactive probes, standard autoradiographic methods may be employed. 
Factors influencing the selection of nuclear emulsion will be, the type and energy of the isotope 
label, the required resolution, and time by which a result must be available. <94> 
Standard immunohistochemical techniques may be used for the detection of non-radioactive 
probes. Haptens/nucleotides such as digoxigenin and biotin may be incorporated enzymatically 
into nucleic acid probes, and detected by anti-digoxigenin and anti-biotin antibodies. These may 
be coupled to all enzymes commonly used in immunohistochemical techniques such as 
peroxidase or alkaline phosphatase (AP). With AP, the 5-bromo-4-chloro-3-
indolylphosphate/nitro blue tetrazolium (BCIP/NBT) reaction is recommended. <94,93> 
When an enzyme is used as the label, endogenous enzyme activity may have to be inactivated. 
For alkaline phosphatase, levamisole may be added to the substrate solution. <93> 
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A recent advance in the labelling technique has been the development of fluorescein-labelled 
haptens/nucleotides. Fluorescein-d[UTP] can be incorporated enzymatically into nucleic acids 
according to standard techniques, and can be detected by an anti-fluorescein antibody coupled 
to an enzyme which can be detected by a secondary antibody which is FITC-labelled. <93> 
Non-specific binding of antisera through protein-protein interactions is also possible. The use of 
a bovine serum albumin blocking step before application of detection reagents may be 
beneficial in reducing the possibility of such reactions. <94> 
4(t) CONTROLS 
Methodological controls should always be included. The processing of a sample known to 
contain target sequences will establish whether the technique is working, and to what extent its 
sensitivity compares with previous analyses. This will be the positive control. Negative controls 
should also be include and may be of two types: 1) a sample without any target sequence which 
is taken through the whole technique; or 2) a sample that contains target nucleic acid but which 
is hybridised without the addition of labelled probe (a probe-negative control). Each will 
demonstrate any non-specific interactions of detection reagents with the sample. <94> 
4(g) APPLICATIONS 
ISH for viral identification has been used extensively, where it is more sensitive than 
immuno-chemistry and more accurate than cytological identification of infected cells. ISH has 
provided information on types of cells infected, and latent infection and thus has contributed to 
the understanding of the pathogenesis of viral infection. <93 ,94,93> 
The development of anticentromeric antibodies which can be detected by ISH has been 
established. Using these antibodies, the mitotic rate and degree of aneuploidy of tumours can be 
assessed. (93 ,94,98) 
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ISH provides precise information on the position of break points in relation to a gene sequence, 
in the investigation of translocations. This has application in the study of hereditable disorders 
such as Alzheimer's disease. <93•98> 
The phenotypic expression of cells can be assessed in cytological preparations at the mRNA 
level using ISH. This can be used to identify cells and to study the physiological control of 
protein synthesis and has application to the study of oncogenes, growth factors, cytokines, 
hormones and their receptors. The correlation of N-myc expression with prognosis in 
neuroblastoma is an example. <93 ,94•98> 
4(h) SUMMARY 
ISH is an important technique being used more commonly as a diagnostic tool in the routine 
laboratory, especially with the availability of non-radioactive probes. More and more are 
becoming commercially available in kit form which contain reagents for nucleic acid sequence 
labelling, and the detection of hybrids, and the general application is widening. 
5. IMMUNOIDSTOCHEMISTRY (IH) 
Cells manufacture protein products (antigens) dependent on their individual genetic expression. 
Different cell-types will express different protein products. Characterisation of cell-types can 
thus be achieved by identification of these specific gene products. 
IH is the in vitro technique whereby identification of these gene products, or antigens, is made 
possible, based on immunological principals of antigen-antibody recognition, and 
histochemical principals of identification of this reaction. 
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The basic technique of IH involves the "artificial" production of a specific antibody 
(immunoglobulin) to the antigen expressed by the cell, the interaction of antibody with antigen, 
and the subsequent recognition/visualisation of this antigen-antibody reaction by an attached 
label. 
Like ISH, IH can be used on tissue that has been fixed in formalin and embedded in paraffin, 
enabling retrospective analyses in archival material. <100> 
There are many manipulations of this basic procedure which enable improved sensitivity and 
specificity, and enhancement of the visualisation. 002•103> Direct IH allows for direct 
visualisation of the antigen-antibody complex whereby the label is directly attached to the 
antibody (see figure 9). Non-specific reactions are limited but since staining only involves one 
labelled antibody, little signal amplification is achieved. <102•103> 
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FIGURE 9 - Direct m technique: Enzyme-labelled primary antibody reacts with tissue antigen(98) 
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The production of "secondary" antibodies, ie antisera raised to first antibody, which are then 
labelled, is the basis of the two-step indirect IH technique (see figure 10). The primary 
antibody now acts as the antigen to the labelled secondary antibody. This allows for 
amplification of the signal and an increased sensitivity over the direct method, as several 
secondary antibodies are likely to react with different epitopes on the primary antibody. <102•103> 
~-, 
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FIGURE 10 - Two-step indirect method: enzyme-labelled secondary antibody reacts with primary antibody bound to tissue antigen<98) 
Bridge techniques, or the three-step indirect method (see figure 11), remove the label to a third 
layer ("tertiary") antibody which has been raised in the same animal as the primary antibody. 
The secondary antibody now becomes the "antigen" to the tertiary antibody and serves as an 
immunological bridge between the primary and tertiary reactants. Efficiency and sensitivity are 
improved because nonspecifically bound secondary antibody is unlikely to bind tertiary reagents 
with high affinity, and large label conjugates do not affect the ability of secondary antibody to 
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bind to primary antigen. <102> • Additional label is placed at the site of tissue antigen and thereby 
produces greater visualisation. This technique is particularly helpful when staining antigens 
with limited numbers of epitopes. <103> 
Many techniques make use of the avidin-biotin interaction which provides a simple and 
sensitive method to localise antigens in formalin-fixed tissues. Avidin is a 68 000 molecular 
weight glycoprotein found in egg white. It posseses an extraordinary affinity for the small 
molecule vitamin, biotin, for which it has four binding sites. Biotin may be covalently coupled 
to either the antibody or to the label. <101 •102, 104> 
A variety of procedures using the avidin-biotin interaction have been developed in quantitative 
IH. One is the labelled avidin-biotin (LAB) technique in which primary antibody is first 
applied, followed by the sequential application of biotin-labelled antibody and enzyme-labelled 
avidin. c102, 10J,1os,106) 
Another is the ABC (avidin-biotin-enzyme complex) method. Here, the sequence of reagent 
application is primary antibody, biotinylated secondary antibody, and then the preformed 
avidin-biotin-enzyme complex. <102•103> The sensitivity of this method is theoretically limited 
only by the number of secondary antibodies bound to primary antibody and the number of 
reactive biotin molecules on each secondary antibody.<103> However, ABC performs less well 
than expected perhaps because of steric constraints limiting the number of biotin sites available 
for avidin binding. 002> 
Steptavidin, like avidin, is a tetrameric protein with four high-avidity binding sites for biotin. It 
has been isolated from Streptomyces avidinii. Unlike avidin, it is not glycosylated and exhibits 
less nonspecific binding at neutral pH. Streptavidin-linked 1H therefore appears to perform with 
greater sensitivity and efficiency for a given antigen density or antibody dilution. <102> 
Detection of the immunological reaction is reliant upon the use of attached labels. Initially, 
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conjugating fluoresceine to antibodies was the methodology employed in IH. This allowed the 
identification of antigen-antibody complexes by the fluorescent emission of blue light, and 
provided good sensitivity. This method, however requires the use of a fluorescent microscope 
and the fluorescence fades easily and cannot be assessed at the same time as morphology. <101 •102> 
IH requires a detection system that can be applied to routinely processed tissues, under 
conditions in which the morphological characteristics are preserved, and allows visualisation by 
standard light microscopic techniques. This has lead to the development of 
immunohistochemical probes in which highly active enzymes are linked to antibody. <102> Unlike 
fluorescein methods which fade, enzyme systems provide a more or less permanent record. <101> 
Enzymes that have been used successfully include intestinal alkaline phosphatase (ALP), 
glucose oxidase, beta-glucuronidase, and acid phosphatase. Of these, ALP has proved 
particularly useful in IH. 002> The horseradish peroxidase (HPO) is another enzyme system 
which has proved useful and has been successfully incorporated into the avidin-biotin 
interaction forming the avidin-biotin-peroxidase complex (ABC). <103-105> 
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FIGURE 11 - Three-step indirect method: enzyme-labelled tertiary antibody reacts with enzyme-labelled secondary antibody(98) 
50 
Introduction 
Enzyme systems require substrates upon which to act. The substrate for HPO is hydrogen 
peroxide (H20i). Together these form a complex which reacts with an electron donor, such as 
diaminobenzidine acid (DAB), to produce the end products of the reaction - a coloured 
molecule (or chromogen) and water (H20). C103> 
Endogenous cellular enzymes require inhibition, since their action cannot be distinguished from 
that of the exogenous enzyme conjugate. CIOl) Peroxidase activity is a common property of all 
haemoproteins such as haemoglobin (red blood cells), myoglobin (muscle), cytochrome 
(granulocytes and monocytes) and catalases (liver and kidneys), and requires inhibition. Cl03> 
IH does not distinguish between antigens synthesised by the cell and those taken up from 
elsewhere. Some antigens may be passively absorbed or phagocytosed, while others may be 
attached to receptors. Conversely, cells may appear negative if they export their synthesised 
product without significant storage. Localisation of specific mRNA by ISH virtually excludes 
phagocytosis, endocytosis and receptor binding, but does not necessarily imply translation. IH 
may be required to confirm protein synthesis. The use of these two procedures in combination 
are complementary and should be equally available in histopathology departments. C101 •103> 
There may be shared reactivity between identical epitopes in different antigens, and cross 
reactivity between a different epitope on a different antigen. This will give the impression of 
enhanced reactivity. C101> Non-specific binding of antibody to the section or section adhesives 
may occur. Inclusion of carrier proteins such as ovalbumin or bovine serum albumin in the 
dilution buffer, or detergents in the washes may help reduce this problem. C101 •103> 
Positive immunohistochemical results are generally assessed semi-quantitatively and are thus 
highly subjective. Attempts are being made for objective quantification by use of densitometer 
or microspectophotometer methods. C101> 
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AIMS OF THE STUDY 
1 To perform a retrospective, epidemiological analysis of cases of reactive lymphadenopathy 
and atypical reactive lymphoid hyperplasia (ARLH) received in the Department of 
Anatomical Pathology, UCT and GSH, over a 5 year period, in order to determine the 
number of cases of ARLH, and the frequency of the various subtypes of reactive lymphoid 
hyperplasia, so as to provide base-line information for further studies. 
2 To set up IN SITU HYBRIDIZATION (ISH) for detection of Epstein-Barr virus 
(EBV)-encoded RNA's (EBERs) in latently infected cells in selected cases, to determine if 
virus is present in ARLH. 
3 To perform immunohistochemical analysis for the detection of EBY-derived latent 
membrane protein (LMP) in those cases subjected to ISH. 
, 
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The material for this study was obtained from the surgical pathology records of the Department 
of Anatomical Pathology, University of Cape Town and Groote Schuur Hospital. Most cases 
emanated from Groote Schuur Hospital (GSH) but some cases were referred from other 
laboratories in and around Cape Town. 
EPIDEMIOLOGICAL ANALYSIS 
The period selected was from the beginning of 1987 to the end of 1991, a five year interval. 
The cases were obtained using the SNOMED coding system, a computerised system used at 
GSH for the permanent record of all pathology cases seen at that institution. A list of all lymph 
node biopsies for that period was obtained. Lymph nodes removed as part of large resections eg 
colectomies with attached lymph nodes, or laryngectomies with lymph node dissections etc, 
were excluded and only those cases where unexplained lymphadenopathy was the reason for the 
lymph node biopsy, were included. 
The surgical report of each biopsy was obtained. Only those conditions displaying atypical 
reactive hyperplasia not further categorized, or those having a diagnosis listed in TABLE 1, 
were included in the study. Conditions such as granulomatous inflammation typical of 
tuberculosis or sarcoidosis, or non-specific reactive lymphadenopathy, not atypical, where the 
possibility of malignancy was clearly not entertained, were excluded. It is important to 
emphasize that the surgical report had to include a diagnosis listed in Table 1, or imply 
atypical reactivity. The reactive condition, sinus histiocytosis, if not further qualified by some 
form of atypia, was also excluded. The conditions excluded occur commonly and are usually 
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not diagnostic problems and seldom confused with malignancy. Cases showing the histological 
characteristics of mv infection were confirmed serologically, but not those showing the 
features of IMN or toxoplasmosis infection. 
The tissue analysed was fixed in 10% formal saline or B5 fixative, followed by routine 
processing and paraffin-wax embedding. All were stained with haematoxylin and eosin. All 
cases included in the study were reassessed histologically and the diagnostic criteria as layed 
out in the relevant literature, were applied. 
A five year retrospective epidemiological analysis of all cases in the study with regard to 
histological diagnosis, age, race, and sex, was performed. 
EPSTEIN-BARR VIRUS IN SITU HYBRIDIZATION 
A cross section of cases of the atypical reactive hyperplasias/reactive lymphadenopathies were 
selected to perform in situ hybridization for EBER 1 and 2. The number of cases selected was 
limited by the expense and limited quantity (0,5ml) of the probe. All cases were formalin- or 
BS-fixed and paraffin embedded. They were sectioned onto APES-treated slides to ensure 
adherence during the procedure. 
The probe was obtained from DAKO laboratories and the specification 1s: 
Fluorescein-Conjugated EBV (EBER) Oligonucleotides, code No.Y 017, lot No. 042. 
The DAKO Fluorescein-Conjugated EBV (EBER) Oligonucleotides is a mixture of two 
30-mers, and has been labelled with FITC. 
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The deoxyribo-oligonucleotides are complementary to the two nuclear EBER RNA' s (EBERs) 
encoded by EBV. The EBERs are thus the target for the DAKO probe. The probe is intended 
for the detection of latent EBV infection by in situ hybridization on formalin-fixed, 
paraffin-embedded tissue sections. 
Following hybridization and a wash with Tris-buffered saline, alkaline phosphatase-conjugated 
Rabbit F(Ab') Anti-FITC (DAKO ISH Detection Kit. Code No. K 046) is added, and the 
specimen is incubated at room temperature for 30 minutes followed by a wash. Enzyme 
substrate (BCIP/NBT) is added, and the specimen incubated at room temperature for 30-60 
minutes, followed by a wash. Included with the enzyme substrate is an inhibitor, Levamisole, 
to block endogenous alkaline phosphatase. Finally the specimen is mounted in glycergel. 
Positive staining is recognised under the microscope as a dark blue colour at the site of 
hybridization. 
As the oligonucleotide probes detect RNA, it is important to avoid contamination of buffers, 
glasswear, and other equipment with RNase. This is of particular importance until the 
hybridization step has been completed as RNase does not digest the RNA-DNA duplexes. All 
glasswear used in the ISH detection was washed with hydrogen peroxide for 30 minutes and 
then treated with DEPC water at 37 °C for six hours. All handling of equipment, reagents etc 
was done using sterile gloves. This is done to minimize contamination by RNase. 
The protocol for one-day ISH as developed by DAKO is as follows (all incubations are at room 
temperature unless otherwise stated): 
A. REHYDRATION Immerse in xylene 
Immerse in 99 % ethanol 
Immerse in 95 % ethanol 
Air dry 
Immerse in pure water 
2x3 min 
2x3 min 
3 min 
2x3 min 
B. PRETREATMENT 
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Add 200µL of proteinase K 
(300µL in PRK-buffer) 
Immerse in pure water 
Immerse in 95 % ethanol 
Immerse in 99 % ethanol 
Air dry 
C. HYBRIDIZATION Add 1-2 drops of EBV Oligonucleotides/FITC 
(undiluted) and cover section with coverslip 
0.1 % Triton X-100 
D. DETECTION 
E. MOUNTING 
Immerse in TBS 
Incubate with approx 200 µL optimally 
diluted Rabbit F(Ab') Anti-FITC/AP 
Immerse in TBS 
Immerse in substrate buffer pH 9. 0 
Incubate with diluted Enzyme Substrate with Inhibitor 
Place in running tap water 
Mount in Glycergel 
Materials and methods 
30 min(@ 37°c) 
2x3 min 
3 min 
2x3 min 
10 min 
2 hrs (@37°C) 
2x5 min 
2x3 min 
30 min 
2x3 min 
3 min 
30-60 min 
5 min 
The stock solutions used as recommended by DAKO for the one-day ISH technigue are: 
10 x PRK-Buffer: 0.50 M Tris/HCl, pH 7.6 
20 x TBS: 1.0 M Tris/HCl, pH 7.6, 3.0 M NaCl 
1 % Triton X-100: 2 g Triton X-100 in 200mL pure water 
0.1 M Tris/HCL: 0,1 M NaCl, 50 mM MgC12, pH 9.0 (substrate buffer) 
Solvent: The labelled oligonucleotides are supplied in hybridisation solution consisting of 30% 
formamide, 10% dextran sulphate, 0, 1 % sodium pyrophosphate, 0,2 % polyvinylpyrrolidone, 
0,2% ficoll, 5 mM Na2EDTA, 50 mM Tris/HCL, pH 7,5. 
The preparation of reagents is as follows: 
Anti-FITC/AP Working Solution: 
Dilute Rabbit F(Ab') Anti-FITC/AP 1:50 to 1:150 in TBS, 0.1 % Triton X-100, 3% BSA. 
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Enzyme Substrate with Inhibitor: 
Dilute Enzyme Substrate 1:50 in 0.1 M Tris/HCl, 0.1 M NaCl, 50 mM MgC12, pH 9.0. Add 1 
µL Inhibitor (Levamisole) to each mL diluted Enzyme Substrate. 
Ten cases were randomly selected for the ISH runs and are numbered 1 to 10. Their 
histological diagnoses are summarized as follows: 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
Atypical reactive 
Kikuchi' s disease 
Atypical reactive 
Atypical reactive 
Atypical reactive 
Atypical reactive 
Atypical reactive 
Atypical reactive 
Atypical reactive 
Atypical reactive 
mixed type 
interfollicular, with lymphoblastoid 
hyperplasia 
interfollicular 
follicular, with 
histiocytosis 
immature sinus 
and epithelioid 
granulomas; toxoplasmosis 
follicular, with follicular lysis; HIV 
follicular; HIV 
mixed 
toxoplasmosis 
interfollicular with T-zone hyperplasia 
The controls used for the ISH runs were lymphoid cells latently infected by EBV and grown in 
vitro on glass slides, and a cell pellet of similarly infected lymphoid cells. The cell pellet was 
paraffin-wax-embedded and sectioned onto APES slides. These controls were obtained from the 
Department of Immunology, UCT. The decision to use the cell pellet was based on the premise 
that this would simulate more closely the conditions to which the routine sections would be 
subjected. 
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Another control was a paraffin-embedded lymph node obtained from Professor Lorenzo 
Leoncini from the Department of Pathology, University of Siena, Italy. This was a case of HD, 
mixed cellularity containing numerous Reed-Sternberg cells latently infected by EBV. 
Initially, two ISH runs only using the control cells grown on the slides, was performed. The 
rehydration step was omitted as was pretreatment with proteinase K as these cells were not 
formalin fixed or paraffin embedded. The run was then carried out as per protocol. The 
omission of the EBV oligonucleotide/FITC probe to one of the slides served as the negative 
control ie a no-probe control. 
The third ISH run made use of the cell pellet and the control lymph node. Again, a no-probe 
control was used for both specimens. Here, the rehydration step was included but not the 
pretreatment with proteinase K. 
The fourth ISH run used the control lymph node and two of the selected cases (1 and 2). The 
control and the cases were pretreated with proteinase K, OµL/ml, 5µL/ml and lOµL/ml 
respectively. For each dilution of proteinase K, there was a no-probe control. The method was 
as per protocol. 
A fifth ISH run again used the lymph node control and five selected cases (3, 4, 5, 6, and 7). 
Proteinase K concentrations used were 5- and lOµL/ml and for each, there was a no-probe 
control. Again the method used was as per protocol. 
A sixth ISH run used the lymph node control and three of the selected cases (8, 9, and 10). 
Proteinase K concentrations were those used in the fifth run, each case and control having a 
no-probe control, and the method as per protocol. 
SUMMARY OF ISH RUNS 
Run Number Case no / tissue 
1 Control cells 
on slides 
2 Control cells 
on slides 
3 Cell pellet 
Control LN 
4 Control LN 
Case 1 
Case 2 
5 Control LN 
Case 3 
Case4 
Case 5 
Case 6 
Case 7 
6 Control LN 
Case 8 
Case 9 
CaselO 
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EBV infected 
EBV infected 
EBV infected 
EBV + HD 
EBV + HD 
Atypical reactive 
-mixed type 
Kikuchi's 
EBV + HD 
Atypical reactive 
-in terf ollicular 
Atypical reactive 
-interfollicular 
Reactive-follicular 
-Toxo 
Folliculysis (HIV) 
Atypical reactive 
-follicular (HIV) 
EBV +HD 
Atypical reactive 
-mixed 
Toxoplasmosis 
Atypical reactive 
-interfollicular 
Materials and methods 
Proteinase K 
concentration 
nil 
nil 
nil 
nil 
0, 5, 10 µI/ml 
5, 10 µI/ml 
5, 10 µI/ml 
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FIGURE 12 - Lymph node control; haematoxylin and eosin - lOOX magnification 
A no-probe control was run with all controls and all cases at each of the different proteinase K 
concentrations. 
LMP IMMUNOHISTOCHEMISTRY 
Identification of the LMP Qatent membrane protein) antigen on cells latently infected by EBY, 
was performed on the cases subjected to ISH, including the lymph node control. This involves 
an immunohistochemical method using a monoclonal mouse anti-EBY antibody. 
The antibody consists of a cocktail of the clones CS 1, CS 2, CS 3, and CS 4 (CSl-4) and is 
obtained from DAKO Laboratories, Code No. M 897, Lot No. 012. CSl-4 mouse monoclonal 
antibody is supplied in liquid form as tissue culture supernatent (RPMI 1640 medium, 
containing fetal calf serum), dialysed against 0.05 M Tris/HCL, 15 mM NaN3 , pH 7 ,2. 
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DAKO-EBV, CS 1-4 reacts with a 60 kD latent membrane protein (LMP-1) encoded by the 
BNLF-1 gene of the EBV. All four anti-LMP antibodies present in the product recognise 
distinct epitopes on the hydrophilic carboxyl region of LMP, which is exposed to the cytosol. 
DAKO-EBV, CS 1-4 can be used on formalin-fixed , paraffin-embedded tissue sections. 
Enzymatic predigestion may enhance staining in tissues that have undergone prolonged formalin 
fixation. 
The technique used for our IH was a LAB method using streptavidin, not biotinylated. 
+ Sections were dewaxed in 96 % alcohol. 
+ A 1 % hydrogen peroxide (HPO) solution m methanol was added to block 
endogenous HPO. 
+ Sections were then washed in running tap water for 5 minutes. 
+ Enzyme predigestion was not used. 
+ Sections were rinsed in a TBS buffer. 
+ They were then incubated with normal rabbit serum for 10 minutes, again as a 
blocking step. 
+ Primary antibody (DAKO-EBV, CS 1-4) in a dilution of 1:25 was then incubated 
with the tissue sections for 30 minutes. 
+ Sections were then rinsed with TBS buffer. 
+ The link antibody was a rabbit-antimouse (RXM) biotinylated antibody, and was 
incubated with the sections for 30 minutes. 
+ Sections were then rinsed in TBS buffer. 
+ Peroxidase-labelled streptavidin was added and incubated with the tissue sections for 
30 minutes. 
+ Sections were rinsed with TBS buffer. 
+ The enzyme substrate, diaminobenzidine (DAB), was then applied for 7 minutes. 
+ Sections were again rinsed with TBS buffer and then washed in water. 
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+ Counterstaining was then done with Mayers haematoxylin. 
+ Sections were washed in running tap water for 5 minutes. 
+ They were then dehydrated and mounted. 
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I EPIDEMIOWGICAL ANALYSIS OF CASES 
During the 5 year period under analysis, there were 126 cases of atypical reactive hyperplasia 
and reactive lymphadenopathy as determined by inclusion criteria. The most common category 
was that of the mixed interfollicular / follicular pattern, with a total of 75 cases (60%). This 
was followed respectively by the follicular pattern with 40 cases (31.75%), the diffuse pattern 
with 7 cases (5.56%), and the sinus pattern with 4 cases (3.17%). 
In all 4 categories, the atypical proliferations not further specified, were the most common 
being 31 (24,6%) in the mixed interfollicular / follicular category, 12 (9,5%) in the follicular, 
3 (2,4%) in the diffuse, and 2 (1,6%) in the sinus category. 
Entities that were commonly diagnosed were toxoplasmosis lymphadenitis with 13 cases 
(10,3%), dermatopathic lymphadenopathy with 12 (9,5%), and florid follicular hyperplasia 
with 9 (7, 1 % ) . Castleman' s disease and Kikuchi' s disease both had 8 cases ( 6, 3 % ) and 
lymphogranuloma venereum had 6 cases (4,8%). Entities less commonly diagnosed were 
cat-scratch disease, AIDS-related lymphadenopthy, and transformation of the germinal centres, 
with 4 cases (3,2%) a piece. IMN, drug-induced lymphadenopathy, and syphilis, each had 2 
cases (1,6%), and those with 1 case each (0,8%) were lymphadenopathy associated with SLE, 
RA, LCH, and the haemophagocytic syndrome. Entities not diagnosed during the 5 year 
interval under consideration were post vaccinial lymphadenitis, AILD, Kawasaki disease, 
SHML, lymphangiogram effect, vascular transformation of sinuses, and lymphadenopathy 
associated with yersinia and Whipple's disease. 
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Table 2 : Frequency of patterns of atypical lymph node - hyperplasia in 126 patients 
Diagnosis Frequency 
Diffuse pattern 
IMN 02 
Post vaccinial lymphadenitis 00 
Drug-induced 02 
Angioimmunoblastic Lymphadenopathy 00 
Atypical proliferations 03 
Mixed interf ollicular If ollicular pattern 
Dermatopathic Lymphadenopathy 12 
Toxoplasmosis 13 
Cat scratch disease 04 
Lymphogranuloma venereum 06 
Yersinia 00 
Kikuchi disease 08 
SLE 01 
Kawasaki disease 00 
Atypical proliferations 31 
Follicular pattern 
Florid 09 
AIDS-related lymphadenopathy 04 
Syphilis 02 
Rheumatoid Arthritis 01 
Castleman' s disease 08 
Transformation of germinal centres 04 
Atypical proliferations 12 
Sinus pattern 
Sinus histiocytosis with massive lymphadenopathy 00 
Haemophagocytic syndrome 01 
LCH 01 
Whipple's disease 00 
Lymphangiogram effect 00 
Vascular transformation sinuses 00 
Atypical proliferations 02 
TOTAL 126 
Relative 
Frequency ( % ) 
1,6 
0,0 
1,6 
0,0 
2,4 
9,5 
10,3 
3,2 
4,8 
0,0 
6,3 
0,8 
0,0 
24,6 
7,1 
3,2 
1,6 
0,8 
6,3 
3,2 
9,5 
0,0 
0,8 
0,8 
0,0 
0,0 
0,0 
1,6 
100 
Results 
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In total, 60 males (47.62%) and 59 females (46.83%) were entered into the study. There were 
7 unknowns (5.56%) as regards gender. The highest number of cases were seen in 1991 with 
30 cases in total followed respectively by 1990 (27 cases), 1987 (24), 1988 (22), and 19~9 
(19). More males were entered in 1988 (12), and 1991 (17). Females were predominant in 
1989 (11) and 1990 (16). Equal numbers of males and females were seen in 1987 with 14 each. 
Of the 2 cases of IMN, 1 was male and the other female, falling into the age ranges of 9 to 19, 
and 20 ot 29 years respectively. One was a White male, the other a Coloured female. 
There were 2 cases of drug-induced lymphadenopathy, the sex and race of both being 
unknown. The ages were in the 40 to 49, and 50 to 59 year ranges. 
All 3 of the atypical proliferations not further specified showing the diffuse pattern, were 
female patients, 1 being in the age range 30 to 39 years, and the other 2 both being in the range 
70 to 79 years. Two were White and 1 Coloured. 
There were 8 male and 4 female patients of the 12 cases of dermatopathic lymphadenopathy, 3 
being White males, 5 Coloured males, 3 Coloured females, and 1 Black female. The age range 
was wide, falling between 30 and 80 years. 
Of the 13 cases of toxoplasmic lymphadenitis, 5 were male and 6 female. The race and gender 
distribution was 2 White females, 5 Coloured males, 4 Coloured females, and 2 unknown. The 
age range was wide being from 10 to 59 years. 
There were 2 cases of cat-scratch disease in each of the gender categories with 1 White male, 1 
Coloured male, and 1 Coloured female. Ages ranged from 10 to 49 years. 
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Of those diagnosed as having LGV, 3 were male and 3, female. There were 2 who were Black 
males, 2 who were Black females, and there was 1 Coloured male and 1 Coloured female. The 
age range was 10 to 39 years. 
Six males and 2 females were diagnosed as having Kikuchi' s disease, 4 of whom were White 
males, 2 were Coloured males and 2 Coloured females. The ages ranged from 10 to 49 years. 
The single case of SLE was that of a Coloured female aged between 10 and 19 years. 
There were 31 atypical proliferations not further specified in the mixed interfollicular -
follicular group. Fifteen were male and 13 female, and 3 were unknown. Their breakdown 
according to sex and gender was 5 White males, 3 White females, 3 Coloured males, 4 
Coloured females, no Asians of either sex, 7 Black males, and 6 Black females. Ages varied 
from 2 in the Oto 9 year old group, 1 in the 10 to 19, 6 in the 20 to 29, 5 in the 30 to 39, 8 in 
the 40 to 49 , and 9 in the 50 to 59 years group. 
Of the 9 florid follicular hyperplasias, 5 were male and 4 female. Two were White males, 3 
Coloured males, 3 Coloured females, and 1 Black male. The other race and gender groups 
were not represented. Ages varied from 10 to 59 years. 
The 4 cases of AIDS-related lymphadenopathy were all males. Three were Black and one was 
Coloured. All 4 cases fell into the 20 to 29 age group. 
There was 1 male case of lymphadenopathy associated with syphilis, and 1 female case. Both 
fell into the age group 40 to 49. One was a Coloured male, the other a Black female. 
The only case of lymphadenopathy associated with rheumatoid arthritis was that of a White 
female aged between 40 and 49 years. 
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Of the 8 cases of Castleman' s disease, 3 were males and 5 females . Two were White females, 1 
a Coloured male, 2 Coloured females,' 2 Black males, and 1 Black female. Ages ranged from 
10 to 59 years. 
The 4 cases of transformation of the germinal centres were all females, 1 White, 2 Coloured, 
and 1 Black. Two occurred in their twenties, 1 in the thirties and 1 in the fifties. 
There were 12 cases of atypical proliferation - follicular pattern, made up of 4 males and 8 
females. Two were White males, 4 were White females, 3 were Coloured females, 1 was an 
Asian male, 1 a Black male, and 1 a Black female. The age range was wide being from 10 
years to 79 years. 
The single case haemophagocytic syndrome was that of a Coloured female in the 30 to 39 year 
age group. 
The single case of LCH was that of Coloured male aged between 10 and 19 years. 
Both cases of atypical proliferation - sinus pattern were Coloured males, 1 between 20 and 29 
years and the other between 30 and 39 yf!al's. 
In total, 52 of the 126 cases (41 %) of ARLH and reactive lymphadenopathy were referred as 
problem cases to our institute. All 3 (100%) of the atypical proliferation not further specified in 
the diffuse category were referred cases as were both of the 2 cases of drug-induced 
lymphadenopathy. Twenty one of the 31 cases (67.74%) of atypical proliferations not further 
specified in the mixed interfollicular / follicular category, and 6 of the 12 (50 % ) atypical 
follicular proliferations were referred cases. Other commonly referred diagnoses were those of 
Kikuchi's disease and Castleman's disease (both 4 of 8, or 50%), cat-scratch disease and 
transformation of the germinal centres (both 2 of 4, or 50%), IMN (1 of 2 or 50%), and florid 
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follicular hyperplasia (3 of 9, or 33.3%). One of the 4 AIDS-related lymphadenopathies (25%) 
was referred, 2 of the 13 cases of toxoplasmosis (15.38%), and 1 of 12 cases of dermatopathic 
lymphadenopathy (8.33%). 
II DETECTION OF LATENT EBV INFECTION BY ISH: 
A positive signal was obtained using the control cells on slides in run 1. It was however faint 
and cellular morphology not well preserved. The no probe control (NPC) was negative. 
A similar signal was obtained in the second run, again with control cells on a slide. The NPC 
was negative. In neither of these first two runs was proteinase K used. 
The third run was performed using the cell pellet with its attendant NPC, and the control lymph 
node also with a corresponding NPC. The cells in the cell pellet again stained only faintly and 
its NPC was negative. Nuclear staining of moderate intensity was obtained in the control lymph 
node. Its NPC was negative. No proteinase K was used in run 3. 
In the fourth run, the control lymph node showed moderate nuclear staining at proteinase K 
concentration, 0µ1/ml, and strong staining at proteinase K concentrations of 5- and 10µ1/ml 
respectively. The NPC did not show staining at any of the proteinase K concentrations. Both 
of the test cases (cases 1 and 2) were negative at all three proteinase K concentrations as were 
their NPCs. 
In the fifth run, the control lymph node showed strong nuclear staining at the proteinase K 
concentrations of 5- and 10µ1/ml respectively. The NPCs were negative at these proteinase K 
concentrations. None of the five test cases (cases 3, 4, 5, 6, and 7) nor their NPCs stained 
positively. 
In run six, the control lymph node stained with strong nuclear positivity at both proteinase K 
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concentrations (see figures 13and 14). The NPCs were negative. Two of the test cases (cases 8 
and 9) and their NPCs were negative. The third test case in this run (case 10), showed strong 
nuclear staining of interfollicular blast cells (see figure 15), at both proteinase K 
concentrations. The corresponding NPCs were negative. 
FIGURE 13 - Lymph node control - positive EBER staining; 40X magnification 
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FIGURE 14 - Lymph node control - positive EBER staining; IOOX magnification 
FIGURE IS - Case 10 - positive EBER staining; IOOX magnification 
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The results are summarized in the table below. 
A positive result is interpreted as nuclear staining with a blue colour and is graded in intensity 
as follows: 
0 
+ 
++ 
+++ 
Abbreviation: 
Table 3 
Run Number 
1 
2 
3 
4 
5 
negative staining 
pale staining 
moderate staining 
intense (strong) staining 
NPC no probe control 
NA = not applicable 
Case Number / T~ue Result at Proteinase K concentration 
(Disease) 0 µ1/ml 5 µ1/ml 10 µ1/ml 
Control cells + 
on slides 
NPC 0 
Control cells + 
on slides 
NPC 0 
Cell pellet + 
NPC 0 
Control LN ++ 
NPC 0 
Control LN ++ +++ +++ 
NPC 0 0 0 
1 (AJypical reactl11e - mixed) 0 0 0 
1-NPC 0 0 0 
2 (Kikuchl's) 0 0 0 
2-NPC 0 0 0 
Control LN NA +++ +++ 
NPC 0 0 
3 (AJypical Reacti11e-lnlerfollic.) NA 0 0 
3-NPC 0 0 
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Run Number Case Number / T~ue Result at Proteinase K concentration 
(Disease) 0 µI/ml 5 µI/ml 10 µ1/ml 
4 (AJJpical Reacthe-lnurfollic.) 0 0 
4-NPC NA 0 0 
5 (AJJpical Reacthe-follicuiar) NA 0 0 
5-NPC 0 0 
. 6 (AJJpical Reacthe - HIV) NA 0 0 
6-NPC 0 0 
1 (AJJpical Reacthe - HIV) NA 0 0 
7-NPC 0 0 
6 Control LN NA +++ +++ 
NPC 0 0 
8 (AJJpical Reactive - mixed) NA 0 0 
8-NPC 0 0 
9 (AJJpical Reactive - Toxo) NA 0 0 
9-NPC 0 0 
10 (AJJpical Reactive - lnterfoU.) NA +++ +++ 
10-NPC 0 0 
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ill IMMUNOHISTOCHEMICAL DETECTION OF LMP 
Immunohistochemical analysis for the detection of EBV LMP was performed on all test cases 
and the positive lymph node control. The cell pellet and slide of EBV transfected cells were not 
included in this study. 
Cells were interpreted as being positive when they showed membrane and cytoplasmic 
staining. (tot) Positive staining was seen in the malignant cells of the positive control (see figure 
16), the same cells that were EBER positive. Only one test case (case 5) showed focal positivity 
of occasional blast cells at the periphery of the lyr:nph node and in the interfollicular region (see 
figure 17). 
FIGURE 16 - Lymph node control - positive LMP staining; lOOX magnification 
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FIGURE 17 - Case 5 - positive LMP staining; IOOX magnification 
A moderate degree of background staining was evident not only in the positive control but also 
in some of the test cases. Granular cytoplasmic staining was seen in granulated cells such as 
eosinophils and neutrophils (figure 18). This was attributed to endogenous peroxidase activity. 
FIGURE 18 - Eosinophils showing granular cytoplasmic staining attributed to endogenous peroxidase activity 
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I DISCUSSION OF THE EPIDEMIOWGICAL ANALYSIS 
The total of 126 cases of atypical reactive lymphoid hyperplasia and atypical reactive 
lymphadenopathy seen at GSH over the five year period under consideration would seem to be 
small. This probably reflects the strict inclusion criteria that were applied to all cases. For a 
case to be included, the report had to indicate a degree of atypical reactivity. Cases such as 
sinus histiocytosis, simple reactive follicular hyperplasia, and dermatopathic · lymphadenopathy 
in which no atypical features were seen, were excluded. Also excluded were lymph nodes 
showing granulomatous inflammation again without atypical features . These would include 
conditions such as caseating granulomatous inflammation typical of tuberculosis, or 
granulomatous inflammation typical of sarcoid. Exclusion criteria may have been too strict and 
an analysis of all reactive lymph nodes including all necrotizing conditions, could have been 
undertaken. This may have reflected differing trends to those seen. 
Histologic patterns of lymph node response to a wide variety of antigenic ·stimuli will, by virtue 
of the inherent immunophysiology of lymph nodes, be similar in many cases. The pattern with 
broadest histological appearance is that of mixed interfollicular / follicular. This accounts for 
the large number of cases that fell into this pattern, 59.52%, as it is the least restricting 
histologically and is the pattern that most reflects the normal histology of the lymph node. It 
reflects a lymph node in which antigenic stimulation has caused activation of both T and B 
compartments and is responding appropriately. (3-S,s , to) The follicular pattern was also 
commonly seen with a total of 40 cases, or 31.75%. Again this reflects a physiological 
response to an antigenic stimulus and is therefore not unexpected. 
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In all four of the major patterns, ie diffuse, mixed interfollicular / follicular, follicular, and 
sinus pattern, the most commonly diagnosed entity was that of atypical proliferation not further 
categorised. These again reflect typical and appropriate lymph node responses to a variety of 
antigenic stimuli and therefore these diagnoses are not unexpected. 
An interesting observation was the large number of referred cases, in total 52 (41 %). These 
were cases referred in to GSH for expert opinion as their histological appearances were 
sufficiently suggestive of possible underlying malignancy as to cause concern. This is to be 
expected as many of the ARLHs are great masqueraders of malignancy. Cl-5) In addition, 
conditions such as AILD and PTGC may herald the onset of, or coexist with, malignant 
lymphoma. (26-29'49•50•52) The atypical proliferation, diffuse pattern is the pattern most likely to 
be misdiagnosed as malignant lymphoma. C3,S,lO) In this category, all 3 of the cases were 
referred. The high percentage of cases referred in patterns showing atypical proliferation not 
further specified in the other 3 categories, reflects the degree of uncertainty these changes instil 
in pathologists who are not lymph node experts. Castleman's disease and Kikuchi"s disease are 
unusual entities which when seen, cause concern. Here again, there was a high percentage of 
referred cases, both being 50% of their respective totals. In the category PTGC, 50% of cases 
were referred. In none of these was there evidence of HD. 
It should be stated that the referral of cases to centres of excellence is in no way a poor 
reflection upon the referring pathologist, but should in fact be lauded and encouraged. In this 
way fewer mistakes are made and patients are less likely to be subjected to unnecessary and 
potentially dangerous treatment protocols. It will also "flag" patients who should be followed 
up carefully and regularly. In turn, this wheel of continuing medical education will be of 
benefit to both patients and pathologists. 
In general the number of males and females in each category was too small to draw significant 
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conclusions. Kikuchi' s disease which shows a predominance of females in most instances<66'68> 
showed an inverse ratio of 6 males to 2 females. This is somewhat unusual but again the small 
numbers make conclusions difficult. All 4 cases of AIDS-related lymphadenopathy occurred in 
male patients and all fell into the age range of 20 to 29. All were non-Caucasian. This 
corresponds to most high risk groups. 
Where numbers were larger, age distributions were wide. Clustering of ages into younger age 
groups occurred in cat-scratch disease, LGV, Kikuchi' s disease, and AIDS-related 
lymphadenopathy. Three of these are infectious diseases occurring predominantly in younger 
age groups. The aetiological agent of Kikuchi's disease is unknown, but most cases occur in the 
young<66,68) 
Observations of ARLHs occurring predominantly in particular race groups are not stated in the 
literature. One exception would be Kikuchi's disease, originally described in Orientals but now 
seen in most parts of the Western world as well. <66'68> In Africa, HN infection occurs · 
predominantly in Blacks and is a heterosexual disease. The small number of cases seen in this 
study (4 cases) precludes drawing any conclusions. 
Although most of the surgical reports suggested possible aetiological agents as a cause of the 
ARLH, only those with features of HIV infection were confirmed by serology. For purposes of 
accuracy of interpretation, serological confirmation of all including toxoplasmosis and IMN 
would have been desirable. 
II ISH 
The first three runs (Run 1, 2, and 3) were an attempt to obtain a suitable positive control 
against which to run the selected cases. This was to ensure validity of results. 
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The choice of an EBV infected B-lymphoid cell line . was based on the premise that these cells 
would express the EBER's in high copy number, and therefore be easily detected by the ISH 
technique. A routine laboratory technique to create an immortalised cell line, is to transfect 
B-lymphocytes with the EBV genome. The cells for this study were obtained from such a cell 
line. 
These cells were grown on slides and therefore formed a thin, uniform monolayer on the slide 
surface. The ISH EBER+ signal obtained using these cells was weak ( +) and this may be 
related to a number of factors. Firstly, the covering may have been sparse ab initio therefore 
precluding a strong signal. Secondly, the lack of a supporting reticulin framework as seen in a 
lymph node, would not have been present. This conceivably could have caused loss of cells, or 
disruption of the delicate cell membrane structures during the ISH protocol which involved 
numerous stringency washing steps. Thirdly, the degree of EBER expression by such a cell line 
is unknown and difficult to quantify, and may be intrinsically low. 
In an attempt to create conditions that would mimic as closely as possible those to which the 
formalin-fixed, paraffin-embedded lymph node tissue would be subjected, the EBY-infected 
lymphoid cells were spun down into a cell pellet. This was then embedded in paraffin wax and 
sectioned onto APES-treated slides in the routine manner. In this way, the "positive control" 
would have to undergo dewaxing, dehydration, and rehydration, steps which would have to be 
applied to the test cases. Again the signal obtained was suboptimal, being only weakly positive 
( + ). Here again, the same three factors discussed above may be involved. 
The setting up of any new laboratory technique requires time and practice, especially when 
performed by staff not formally trained in such procedures. Initial runs may understandably not 
be as successful as expected and improvement in technique comes 
with repeated exposure to the protocol. 
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An RNase-free environment is a prerequisite for ISH techniques employed in detecting mRNA. 
At every prehybridization step in the protocol there is a danger of RNase contamination 
occurring which, should it happen, would result in a reduction in ISH signal. <9B> Here again, 
inexperience or improper technique in in situ work could play a role in RNase contamination. 
A known positive lymph node control which was formalin-fixed, and paraffin-embedded, was 
obtained after runs 1 and 2 had already been completed. This control was used for all further 
runs (runs 3, 4, 5, and 6), and allowed for complete adherence of the control to the protocol. 
In this way controls and test cases were subjected to identical conditions in all steps. 
Run 3 was done using the cell pellet and the lymph node control, and both were thus subjected 
to identical conditions. The EBER+ signal obtained by the cell pellet was weak ( + ), and that 
by the lymph node control, moderate ( + + ). The reason for the cell pellet signal not being as 
strong is not immediately apparent but may be related. in some way to the preservation of the 
lymph node structure and the intact surrounding microenvironment of the control lymph node, 
which is not present in the cell pellet. (The protocol has after all been devised for use in 
formalin-fixed, paraffin-embedded tissue.) 
Proteolytic enzyme digestion with proteinase ~ for enhanced exposure of target nucleic acid, 
and thus for enhanced hybridization and signal formation, is a well known and invariably used 
step in ISH work. In run 4, three different proteinase K concentrations were used; 0-, 5-, and 
10µ1/ml. Staining intensity of the control lymph node was enhanced from moderate ( + +) to 
strong ( + + +) by using proteinase K, 5- and 10µ1/ml. There was no apparent difference in 
signal detection between the 5- and 10µ1/ml concentrations. For these reasons, only proteinase 
K, 5- and 10 µI/ml were used in the last two runs. The improved signal obtained in the control 
lymph node with the use of proteinase K may also account for the improved staining intensity 
between run 3 (no proteinase K) and run 4. Here again, increased familiarity and experience 
with the ISH technique could be a factor. 
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In all six runs, a no-probe control (NPC) was used for the negative control in each run and for 
all test cases, and at each proteinase K concentration. This involved omitting the addition of the 
EBV oligonucleotide/FITC-labelled probe to an identically prepared slide. Apart from this one 
change, the NPC' s were taken through the ISH protocol as for the other slides. The NPC' s 
would therefore act as the negative controls for each case and for each of the positive control. 
In each of the runs, a positive signal was obtained from the positive controls, and no signal was 
obtained from the NPC's. This confirms that no false positive results were obtained, and that 
each of the positive signals was indeed positive. The runs were therefore successful in each 
instance. 
Another form of control is that of a truly negative control ie, a lymph node known not to 
contain EBV mRNA. In this instance, the EBV oligonucleotide probe would be added to the 
control slide but as the complementary RNA sequence is not present, no hybridization can take 
place. This is a preferable situation as an exact simulation of the protocol would be possible. It 
would, however involve finding a suitable lymph node control by active exclusion of EBV 
mRNA by serology and sophisticated techniques such as the polymerase chain reaction. Given 
the high incidence of EBV serological positivity in our community, such a negative control 
would be impractical and difficult to find. 
Only one test case was positive, case 10 (atypical reactive - interfollicular, with T-zone 
hyperplasia), and showed strong hybridization signal in occasional interfollicular immunoblastic 
cells. Strong positivity was seen for proteinase K concentrations of both 5 and 10 µl/ml. The 
corresponding NPC' s were negative. 
Niedobitek et al in their study of non-neoplastic lymphoid tissue using an ISH technique for the 
detection of EBER's, found EBV positivity in 50% to 70% of lymph nodes showing nonspecific 
80 
Discussion 
follicular and/or extrafollicular hyperplasia. The relative number of positive cells was small 
and, in most cases, located to to the extrafollicular zones. EBER-specific signals were mainly 
located to small lymphocytes, the proportion of positive lymphoid blasts rarely exceeding 20%. 
This is related to whether the infection is primary, in which case blast positivity is 
predominant, or persistent, where positivity is predominantly in small lymphoid cells. (2) 
Six test cases fell into the nonspecific follicular and/or interfollicular hyperplasias. Of these, 
only one (case 10) showed an EBER positive signal, a proportion lower than that seen by 
Niedobitek. 
In case 10, the EBER+ cells were located in the extrafollicular areas and appeared to consist 
predominantly of lymphoid blasts. Although the EBER+ signal was strong, the number of 
positive cells was small, a finding in keeping with those of Niedobitek. The fact that only blast 
cells were positive could indicate that infection was primary and not persistent. 
They also studied nine lymph nodes from HIV positive individuals. All of these cases had 
interfollicular EBER positive cells in a slightly higher proportion to lymph nodes from 
immunocompetent individuals. <2> Two test cases suggestive of HIV infection (cases 6 and 7) 
were studied. Neither were EBER positive. This could relate to the fact that, although the 
histological appearances were suggestive of those of HIV infection, serological confirmation 
was not available. 
One case of Kikuchi's lymphadenopathy was studied (case 2). An EBER positive signal 
was not obtained. References to EBV positivity in Kikuchi's disease are not available. 
Case 5 was that of a florid follicular hyperplasia with immature sinus histiocytosis and 
epithelioid granulomas, suggestive of toxoplasmosis infection. An EBER positive signal was 
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not obtained. Niedobitek et al studied 13 cases of toxoplasmosis lymphadenitis. Seven displayed 
EBER positive cells, again mostly in the interfollicular areas with occasional positivity in the 
follicular mantle. (2) 
It is important that only nuclear staining be interpreted as positive. EBER mRNA is a nuclear 
product and should not be present in the cytoplasm. In the positive test case and the control, 
only nuclear staining was detected in keeping with observed phenomena. 
ill LMP 
LMP positivity occurring in Hodgkin's and Reed-Sternberg cells in the positive lymph node 
control is to be expected in the light of positivity occurring with the EBER ISH. This is borne 
out in a study by Hummel et al, who examined the expression of EBY-related gene products in 
lymph nodes of patients with Hodgkin's disease and normal lymph nodes, by both ISH for 
EBERs, and immunohistochemistry for LMP. LMP expression was detectable only in the 
neoplastic cell population of those cases _ with EBER-positive tumour cells, although at a lower 
percentage. EBER-ISH positive cells could also be seen in non-malignant bystander cells, in 
some lymph nodes as an isolated phenomenon without positivity of the malignant cells, but in 
others in association with positive malignant cells. EBV was detected by EBER,.JSH in 25 % of 
the control group cases consisting of normal lymph nodes. None of the control lymph nodes 
were positive· for LMP. (SO) The failure to detect LMP positivity in case 10 can be explained on 
this basis. A technical error is unlikely as LMP expression was detected in the positive control. 
One case ( case 5) showed what appeared to be positive LMP staining of lymphoid cells, and 
was seen predominantly on the periphery of the lymph node. This case did not show EBER 
positivity. This can be interpreted as either true positivity, or as 
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non-specific staining. In Hummels study, only malignant cells stained positively for LMP. (SO) 
Non-specific staining and the high incidence of background staining can be attributed to a 
number of factors. Hydrophobic binding between tissue proteins and the antibody molecules 
can occur. This can be overcome in part by lowering the ionic strength of the diluent, adding 
detergent to the diluent or raising the pH of the diluent. <101 ,103,105> 
Ionic/electrostatic interaction between proteins can also result in non-specific binding. This can 
be reduced by using diluent buffers of higher ionic strength, or by adding 0.1 to 0.5 M 
Nac1<103> • 
Most causes of diffuse non-specific background staining are as a result of a combination of 
hydrophobic and electrostatic forces. Unfortunately remedies for one cause may aggravate the 
other. 
Endogenous peroxidase activity is a common property of haemoproteins such as haemoglobin 
(red cells), and cytochrome (granulocytes, monocytes), amongst others. In many of the test 
cases, positive staining of granulocytes, especially eosinophils, and monocytes was seen. 
Suppression can be achieved by incubation of sections with 3 % H202 in methanol, as was done 
in the test cases. Insufficient blocking of endogenous peroxidase activity may account for the 
positivity seen in the granulocytes in the test cases. <101 ,103,105> 
The presence of naturally occumng or contaminating antibodies, which could cause cross 
reactivity, can be blocked by incubation with rabbit serum, as was done in the test cases. 
Tissues such as liver and kidney contain large amounts of endogenously occurring biotin. This 
will lead to non-specific binding of avidin or streptavidin, but may be overcome by the addition 
of avidin to block endogenous biotin. The amount of endogenously occurring biotin in lymph 
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. hi h d h ti . 'fi f 'ti b' d' (101 103 105) nodes 1s not g , an t ere ore not a s1gm 1cant cause o non-spec1 1c m mg. ' ' 
When the tissue marker to be stained has diffused from its site of synthesis or storage into the 
surrounding tissue, it may produce specific background staining. This may also occur when the 
tissue marker is present in high concentrations in blood plasma and has perfused the tissue prior 
to fixation. This is a particular problem when staining for immunoglobulins especially when 
tissue fixation has not occurred promptly. Another form of specific background staining may 
result from ingestion by phagocytes of target antibody, and result in staining not normally seen 
in such cells. (101,10J,1os) 
Non-specific cross-reactivity of an antibody with similar epitopes on different antigens may also 
be the cause of confusing background. 
When the background staining is diffuse and involves most tissue elements, the possibility of 
physical injury such as tissue drying, poor fixation, or the presence of necrosis, should be 
considered. (101 ,10J,1os) 
The small number of cases (10) studied by in situ hybridization and immunohistochemistry 
precludes any conclusion as to the role or association of EBV in the pathogenesis of the atypical 
lymphoid hyperplasias (ALH) as listed in Table 1. This would require a further study using a 
larger number of cases, and possibly concentrating on one or a few pathological entities. The 
association of EBV in certain malignancies is now well established, but little is known of the 
role of EBV in the ALH's. Niedobitek et al have commented on the presence of EBER positive 
cells in non-neoplastic lymphoid tissue, but have not drawn any conclusions as to the role of 
EBV in the pathogenesis of these entities. (2) Recent studies by Bronniman et al have shown that 
Castleman's disease is an EBV associated disease by the identification of EBV DNA in 70% of 
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cases studied. <105> Continued investigations of this nature should elucidate further the role of 
EBY in the ALH' s. 
A useful aspect of this study has been the establishment of a successful ISH technique for the 
detection of EBY, which can now be used either for diagnostic work, or for further 
investigative research. This has provided the writer with an in depth understanding of an area 
of molecular pathology ie in situ hybridization, as well as the acquisition of the laboratory skills 
necessary to perform such work. In situ hybridization is a molecular technique that is acquiring 
an increasingly important and wider role in diagnostic pathology and will be used with 
increasing frequency in the near future. 
No conclusions can be drawn from the results obtained by immunohistochemical detection of 
the LMP of EBY. Once again the application of this technique in conjunction with ISH to a 
larger number of cases of ARLH, and again concentrating on specific entities, could shed light 
on the role of EBV in the pathogenesis of the ARLHs. 
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